Podcasts about jdrf

Legendary WCNC Charlotte weatherman Larry Sprinkle is smashing that alarm clock and handing off his weather clicker after 40 years with the NBC affiliate in Charlotte.Sprinkle, who has been a longtime staple on the station's morning show, will still be with the station. While he hands off weekday morning responsibilities to meteorologist Chris Mulcahy, Sprinkle will continue to share community stories with viewers. He will often lend his smile to pet adoption segments and charity events.Ahead of his final morning show, the Carolina Weather Group's James Brierton talked with Sprinkle about his career, which has touched countless Charlotteans over the years.WCNC Charlotte is hosting a week of events to celebrate Sprinkle. After throwing out the first pitch at the Charlotte Knights game on Wednesday, Sprinkle can also be seen at:Coffee with SprinkleWhen: Friday, April 4, 8 to 10 a.m.Where: Amelie's at Park Road Shopping Center, 524 Brandywine Rd, Charlotte, NC 28209What: Join Sprinkle for a morning of coffee, conversation, and memories.The Schiele Museum EventWhen: Saturday, April 5, 10 a.m. to noonWhere: Schiele Museum, 1500 E Garrison Blvd, Gastonia, NC 28054What: Celebrate Sprinkle's milestone with a special event at the museum. Tickets are available for purchase.Donate: Sprinkle loves animals! Support a cause close to his heart when you bring a can or bag of pet food and exchange it for a raffle ticket and the chance to win a gift basket. One ticket equals every can or pound of food. Drawing will happen at 12 p.m. Saturday, April 5 at The Schiele Museum. Cat and dog food will be donated to The Carlee Cause, a Gaston County organization committed to helping unwanted pets find love and security in new homes.Charlotte AutoFairWhen: The AutoFair runs Thursday, April 3 - Saturday, April 5 at Charlotte Motor Speedway. Larry Sprinkle will help with the closing ceremonies and awards on Saturday, April 5 from 3 p.m. to 5 p.m. Where: Charlotte Motor Speedway, 5555 Concord Pkwy S, Concord, NC 28027What: Larry will help award the “Best of Show” car. Tickets are available for purchaseA remarkable careerSprinkle's broadcasting journey began at just 14 years old as a DJ at WBBO radio in Forest City, North Carolina. This early start led to a successful career in radio that took him across the Carolinas and Tennessee. With a passion for weather, Larry pursued his college education wherever his radio career took him, attending East Carolina University, the University of Memphis, and UNC Charlotte.In 1985, Larry's career shifted when he joined the weather team at WCNC Charlotte, where he has remained for almost four decades. For 27 of those years, Larry has been delivering weather reports as part of the morning news. Throughout his career, he has covered a wide range of weather events, from severe storms and hurricanes to everyday forecasts, providing viewers with vital information to help them stay safe and prepared.Beyond his weather reports, Larry has devoted himself to various charities, including Make-A-Wish, JDRF, the Salvation Army, and Boys and Girls Clubs. His dedication to these causes has made a significant impact on the community. He has helped nonprofits raise an astounding $27 million throughout his career. #northcarolina #southcarolina #weather #ncwx #scwx #podcast

Cliff Avril is a former NFL defensive end who had a standout 10-year career, beginning with the Detroit Lions in 2008 and later winning a Super Bowl with the Seattle Seahawks in 2013. Known for his speed and defensive prowess, Cliff earned a Pro Bowl selection in 2016 and made history with the fastest score in a Super Bowl. Off the field, he's a dedicated philanthropist, co-founding the Cliff Avril Family Foundation in 2014 to support health initiatives and youth programs. His foundation's impact stretches globally, building schools and homes in Haiti. Cliff also serves on the boards of JDRF and St. Thomas, and continues his entrepreneurial journey through real estate ventures with CA Family Properties. Here's some of the topics we covered: Inside Cliff's NFL Journey Top Secrets to Finding Multifamily Deals The Surprising Link Between NFL Teamwork and Multifamily Success Why You'll Never Truly Learn Until You Dive In How to Keep Your Kids Grounded in a Fast-Paced World Building Your Winning Game Plan for Multifamily Real Estate Mentoring the Next Generation for Massive Success Conquering the Fear of Leaving Your Comfort Zone Cliff's Incredible Foundation and Life-Changing Charity Work To find out more about partnering or investing in a multifamily deal: Text Partner to 72345 or email Partner@RodKhleif.com    For more about Rod and his real estate investing journey go to www.rodkhleif.com   Please Review and Subscribe  

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In today's episode, I sat down with Kristy Roby, the market director at Breakthrough T1D central and southern Ohio chapter, and Samantha Reddan, a T1D and podcaster. We talk about the upcoming summit and why you should register and attend. Looking for community and want to meet other Diabetics, yeah, we got you! Looking for education on how to live a more fulfilled life with Diabetes, we definitely got you! Central Ohio Summit Registration - 2/1/25Southern Ohio Summit Registration - 2/2/25The Samantha Show - Samantha's PodcastCoach Ken's Resources:Website: www.simplifyingdiabetes.comNewsletter Sign Up"More Than A1C" - My Signature Coaching ProgramThe Diabetes Nutrition Master CourseThe 5-Pillars Of Diabetes Success WorksheetShopSupport & Donate To The PodcastThe T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for Diabetes research. Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes.You can make an impact on the future of Diabetes now! Fill out an online  survey and gain access to tons of new research and the online portal. It only takes 10-15 minutes.Have a question, send me a DM or email. I'd love to connect and answer any questions you have.You can find the show  on any platform you listen to your podcasts!Don't forget to click on that subscribe button and leave a 5-star review, so you're notified when new episode drop every week.Questions about diabetes, don't hesitate to reach out:Instagram: @CoachK3NInstagram: @thehealthydiabeticpodFacebook: @Simplifying Life With DiabetesEmail: ken@simplifyingdiabetes.comPodcast Disclaimer: Nothing that you hear on The Healthy Diabetic Podcast should be considered medical advice or otherwise; please always consult your medical TEAM before making any changes to your Diabetes management.Support the show

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Dexcom updates investors on its 15-day sensor, TrialNet marks a big anniversary, Beta Bionics goes public, NFL fans support Mark Andrews and much more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Couple of quick updates from the JP Morgan Healthcare Conference. Dexcom's CEO Kevin Sayer expects to launch a 15-day sensor in the second half of the year. That's in front of the FDA right now. Competitor Abbott currently has 15-day sensors with its Freestyle Libre 2 Plus and Freestyle Libre 3 Plus devices, which the FDA cleared in 2023. Sayer also talked about expanded insurance coverage for the G7, to include more people with type 2. They haven't pursued that with Stelo, the OTC version of their sensors. The company has begun work on a next-generation CGM. Sayer said the sensor will be smaller, less expensive and include better electronics. Dexcom is also studying new sensor probes, one of which can support multiple analytes, such as measuring lactate or ketones in addition to insulin.   https://www.medtechdive.com/news/dexcom-ceo-stelo-otc-strategy-jp-morgan/737424/ XX TrialNet reaches a big milestone – more than a quarter million people have learned their risk of developing T1D through screening. TrialNet screening is available to family members of those diagnosed with T1D. Having a family history of the disease places individuals at a 15 times greater risk than those with no family members with T1D. Over the course of VUMC's 18 years participating in the program, the community of T1D patients has become increasingly more engaged with research efforts. More than ever, there is an eagerness to give back to others by participating in clinical trials that could help revolutionize care for those diagnosed with or at risk of developing T1D. In such trials, TrialNet typically takes drugs already shown to be effective in treating other autoimmune diseases and seeks to determine their efficacy in treating, delaying or preventing T1D.   Spencer Mannahan, a 10-year-old patient at Monroe Carell Jr. Children's Hospital at Vanderbilt, is participating in a TrialNet study that is looking to determine whether a treatment regimen using both rituximab and abatacept can preserve insulin production in patients newly diagnosed with T1D. Russell, one of the PIs for the study (Protocol TN-25), also treated Spencer's father, Zach, when he was diagnosed with T1D as a child. She enrolled in a different TrialNet study (Protocol TN-31) examining the effect of abrocitinib and ritlecitinib on insulin production in newly diagnosed individuals. While the possibility exists that her insulin production could be preserved, O'Neal joined the study because it presented an opportunity to make a positive impact on future patients.     These clinical trials support TrialNet's goal of a future without T1D. Research is underway on new methods of blocking the advance of T1D in patients with diabetes-related antibodies. One study will investigate whether T cells that have been activated against insulin can be specifically targeted, rather than issuing a treatment that targets all the body's T cells (thus rendering the patient immunocompromised).   TrialNet, the largest clinical trial network assembled to change the course of Type 1 diabetes, is funded by the National Institutes of Health through grant number NCT00097292.   For more information about screening for Type 1 diabetes risk if it runs in your family, contact info@trialnet.org, visit www.trialnet.org, or contact the Vanderbilt Type 1 Diabetes TrialNet Program at 615-936-8638. https://news.vumc.org/2025/01/22/milestone-in-vumc-affiliated-diabetes-screening-and-research-program-underscores-impact-of-clinical-trials/   XX Another study links air pollution to type 2 diabetes. This is from Wayne State University, and established a robust association between exposure to benzene, a prevalent airborne volatile organic compound, and insulin resistance in humans across all ages. “In this study, we exposed mice to benzene to see how it affects their blood glucose levels and energy expenditure,” she explained. “Our research revealed that within seven days of exposure, they developed high blood glucose insulin levels.” https://today.wayne.edu/medicine/news/2025/01/23/study-links-air-pollution-exposure-to-type-2-diabetes-susceptibility-65321 XX Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher rates of remission compared with calorie restriction alone. The researchers say this study provides a practical strategy to achieve remission for patients with early type 2 diabetes. As well as helping to lower blood sugar levels, SGLT-2 inhibitors can also lead to weight loss, but their effect alongside calorie restriction on diabetes remission has not yet been investigated in a randomised controlled trial.   To address this, researchers carried out a trial involving 328 patients with type 2 diabetes of less than six years' duration at 16 centres in mainland China from 12 June 2020 to 31 January 2023.   Participants were aged 20-70 years with a body mass index (BMI) greater than 25 and were not taking any anti-diabetic medication other than metformin. https://www.news-medical.net/news/20250123/Dapagliflozin-and-calorie-restriction-show-higher-remission-rates-in-type-2-diabetes.aspx XX Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its artificial pancreas system for people with Type 1 diabetes. That's as we're recroding, it's likely they will have begun trading on the NASDAQ by now.. the ticker is BBNX. Beta Bionics' iLet system was first cleared by the FDA for people ages six and up with Type 1 diabetes in May 2023. The Fierce Medtech Fierce 15 winner has since expanded its blood sugar sensor compatibility to include Abbott's FreeStyle Libre and Dexcom's G6 and G7 platforms. The company also said it plans to pursue new clinical studies and an FDA clearance that would enable the iLet's use among people with Type 2 diabetes. The ultmite goal is to have a dual-chambered pump with both insulin and glucagon.. but I didn't find anything about that in the articles about this IPO.. I followed up with Beta Bionics and they told me that the dual chambered pump is still very much the goal. Not sure why most of the publications left that out.. but good to hear. https://www.fiercebiotech.com/medtech/artificial-pancreas-maker-beta-bionics-aims-raise-120m-nasdaq-ipo XX Large new study estimates the size of the current US population with type 1 diabetes and project growth over the next ten years. They say about 2 million live with type 1.. about 1.79 million adults and 290-thousand children. Growth in the ten years is predicted to be about 10% https://jheor.org/article/124604 XX The American Diabetes Association® (ADA) teams up with Xeris Pharmaceuticals® makers of Gvoke – ready to use emergency glucagon. It is estimated that up to 46% of people with type 1 diabetes and 21% of those with type 2 diabetes using insulin experience at least one severe hypoglycemia event each year.2 The ADA, with support from Xeris, seeks to rectify the low rates of appropriate glucagon prescriptions by developing education materials and training resources for health care professionals and people living with diabetes, as well as through a national awareness campaign to educate people on who is at risk for severe hypoglycemia and should have glucagon, preferably ready-to-use, as a safety net. https://www.prnewswire.com/news-releases/the-american-diabetes-association-and-xeris-pharmaceuticals-announce-national-collaboration-to-provide-life-saving-hypoglycemia-education-and-awareness-302355703.html XX XX Wearing a CGM makes pharmacy students better at counseling patients. New study randomly assigned students to wear a CGM during lab sessions.. those who did had a higher average counseling score during the encounter with a patient and a higher overall confidence score. There was also a statistically significant positive correlation between average confidence and average empathy, and empathy and counseling performance. https://www.drugtopics.com/view/hands-on-cgm-training-helps-student-pharmacists-prepare-for-career XX Mark Andrews Bills Mafia Baltimore Ravens tight end Mark Andrews received a host of negative attention after flubbing a potential game-tying two-point conversion in Sunday night's loss to the Buffalo Bills.   In the face of the online rage, Bills Mafia is again showing some support.   Bills fan Nicholas Howard kicked off a GoFundMe to back Breakthrough T1D, a global Type 1 diabetes research organization that Andrews has supported.   "As many of you know, Ravens TE wasn't able to catch the game-tying 2-point conversion and upset Ravens fans," Howard wrote. "On top of that, the TE has been receiving death threats and nasty comments after his performance last night. We want Bills Mafia to donate to Marks charity for [Type 1] diabetes."   As of Wednesday morning, the fund raised more than $50,000 for the charity.   Related Links Lamar Jackson, Ravens bemoan missed opportunities in loss to Bills, defend Mark Andrews Ravens WR Zay Flowers: Missing 2024 playoff run due to injury 'took a little toll on me' Biggest winners and losers from Sunday's Divisional Round NFL playoff games The Ravens thanked Bills fans for supporting Andrews.     "Shout out to Bills Mafia for showing support to our guy Mark Andrews and donating to the [BreakthroughT1D] organization, which works towards curing and improving the lives of those dealing with Type 1 diabetes," the club posted.   Andrews was diagnosed with Type 1 diabetes as a child, an autoimmune disease for which there is currently no cure. He's one of several NFL players diagnosed with Type 1 -- Kansas City Chiefs tight end Noah Gray is another.   "Breakthrough T1D [formerly JDRF] greatly appreciates the generosity of the Buffalo Bills community and the many fans who were compelled to donate after Sunday's game," the organization said in a statement to ESPN's Alaina Getzenberg. "These donations will support research and advocacy on behalf of the 1.6 million Americans who, like Mark Andrews, live with type 1 diabetes."   It's not the first time that Bills fans have donated to the cause of a non-Buffalo player. Back in January 2018, Buffalo fans famously donated to the charity of former Cincinnati Bengals quarterback Andy Dalton after his win over Baltimore helped Buffalo make its first playoff appearance in nearly two decades. Over and over again, Bills Mafia has shown it will support a good cause when some spew hate. https://www.nfl.com/news/bills-fans-supporting-ravens-te-mark-andrews-after-drop-by-donating-to-type-1-diabetes-research

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: World Diabetes Day roundup, existing drugs examined for T1D prevention, Blue Circle Health expands its novel T1D care model, Mounjaro studied further, Canada approves a new pumps system, and tragedy in the diabetes community.  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Of course, World Diabetes Day was yesterday. November 14 marks the birthday of Sir Frederick Banting. who discovered insulin along with Charles Best in 1922. Lots of the tech companies are taking action.. I'm going to link up a great article highlighting what many of them are doing…. from Medtronics Blue Balloon challenge to Dexcom's Nick Jonas video and a lot more. https://www.drugdeliverybusiness.com/world-diabetes-day-2024/ XX A new triple combo therapy could restore insulin production in people with type 1 using existing medications. Levicure's triple-combo oral therapy is already considered very safe, because it involves two drugs approved by the U.S. Food and Drug Administration (FDA) and a well-known supplement. The therapy is a combination of: DPP4-inhibitors, a common type 2 diabetes medication Proton pump inhibitors (PPIs), a drug for severe acid reflux A proprietary version of gamma-aminobutyric acid (GABA), a supplement often used to treat anxiety Levicure says the combined effect can block beta cell destruction, suppress autoimmunity, and restore beta cell function. So far, Levicure's triple therapy has gone through only one retrospective chart review; it has not been put to the test in a randomized controlled trial https://www.diabetesdaily.com/blog/can-this-triple-combo-oral-therapy-restore-insulin-production-733261/   XX Blue Circle Health is expanding it's unique approach to type 1 care. Already active in Florida, Maine & Vermont, it will now be in Delaware and Ohio. Blue Circle Health is free and develops a personalized care plan for each participant, tailored to their unique needs, and offers comprehensive multidisciplinary support over a six-month period. It's paid for by the Helmsley Charitable Trust. The program is available to people 18 years of age and older that speak Spanish or English, regardless of insurance coverage or citizen status. We've got an upcoming podcast episode all about Blue Circle coming up soon. https://www.prnewswire.com/news-releases/blue-circle-health-expands-to-delaware-and-ohio-to-address-health-system-barriers-to-type-1-diabetes-care-and-education-302304170.html XX An international team of experts has created the world's first evidence-based guide for eating lower and low carb. The group says until now, people with type 1 diabetes and their healthcare providers have lacked comprehensive resources to help implement this approach safely and effectively. The guide provides essential information for dietitians and nutritionists and empowers them to work collaboratively with individuals and families who are interested in reducing carbohydrates. It's free and we've got the download link in the show notes. https://www.newswire.ca/news-releases/international-team-launches-first-guide-for-carbohydrate-reduction-in-type-1-diabetes-883729104.html XX A new pump system is available in Canada. mylife YpsoPump insulin pump and CamAPS FX hybrid closed-loop algorithm by Health Canada. mylife Loop consists of the mylife YpsoPump, a lightweight intuitive insulin pump, integrated with the CamAPS FX hybrid closed-loop, a mobile phone-based algorithm, and the Dexcom G6 Continuous Glucose Monitoring (CGM) System. Working together, these components provide an innovative, automated insulin delivery (AID) system designed to simplify insulin therapy and improve glycemic control for Canadians living with diabetes.   "The approval of the mylife YpsoPump and CamAPS FX marks an important milestone as we bring these advanced technologies to the Canadian market," said Sébastien Delarive, Chief Business Officer of Ypsomed Diabetes Care. "Although Ypsomed is relatively new in Canada, our established leadership in diabetes care throughout Europe provides a solid foundation for delivering innovative solutions to Canadians living with type 1 diabetes."   "We are excited to see both mylife YpsoPump and CamAPS FX approved," said Karina Schneider, General Manager at Ypsomed Canada. "This step brings us closer to offering an integrated solution that will help simplify diabetes management for Canadian patients, empowering them to take more control of their health." https://finance.yahoo.com/news/ypsomed-camdiab-receive-health-canada-205500840.html XX The FDA updates the labels for all GLP-1 receptor agonists with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are semaglutide (Ozempic, Rybelsus, Wegovy); liraglutide (Saxenda, Victoza); and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 tirzepatide (Mounjaro, Zepbound). the Medication Guide section of the label also has new additions. Patients are counseled to tell their healthcare provider if they are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). They are alerted that the GLP-1 RAs they are taking may cause serious side effects, including food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sedation. Patients are advised to tell all their healthcare providers that they are taking a GLP-1 RA before they are scheduled to have surgery or other procedures. https://www.medscape.com/viewarticle/fda-updates-glp-1-label-pulmonary-aspiration-warning-2024a1000k84?form=fpf XX Following an impressive data drop this summer highlighting the potential for Eli Lilly's tirzepatide to stave off progression to Type 2 diabetes in prediabetic patients, the Indianapolis-based drugmaker is laying out full results from its longest completed study of the dual GIP/GLP-1 receptor agonist to date. In the three-year SURMOUNT-1 trial, tirzepatide curbed the risk of disease progression to Type 2 diabetes by 94% versus placebo in adult prediabetes patients who were obese or overweight, Lilly said in a release Wednesday. The number represents a pooled result from three tirzepatide doses (5 mg, 10 mg and 15 mg) studied in the trial.   Putting those results into perspective, one new case of diabetes could be prevented for every nine patients treated with tirzepatide, which is marketed in the U.S. as Mounjaro for Type 2 diabetes and as Zepbound for obesity, Lilly said. https://www.fiercepharma.com/pharma/lilly-unwraps-detailed-data-showing-tirzepatide-kept-nearly-99-pre-diabetic-patients XX Edgparke commeical? XX https://www.bloomberg.com/news/articles/2024-10-25/apple-secretly-tests-blood-sugar-app-in-sign-of-health-ambitions XX XX And finally, many of you have likely already heard but we had some incredibly tragic news in the diabetes community, especially for the Breakthrough T1D ride community. I'm going to read from the Breakthrough T1D website: The leadership, staff, and volunteers of Breakthrough T1D mourn the tragic, sudden loss of five T1D Champions on Friday, Nov. 1, 2024.  Jeff and Michelle Bauer, Josh and Tammy Stahl and Barry Sievers were all killed in a singe car crash. The group included two married couples and one single individual—all very close friends and veteran Breakthrough T1D Ride participants. Of this incredibly impactful group, I knew Michelle Bauer personally, I met her as Michelle Alswager – you may know her as Jesse's mom. Her son, Jesse died from complications of type 1 in 2010. And that year, mile 23 on the JDRF ride was created as a mile of silence in memory of Jesse.  Now all riders are asked to ride in silence for that mile not only in memory of Jesse, but all those lost to type 1 diabetes. Michelle wrote her book, Jesse Was Here and created a program that's part of Beyond Type 1 to this day, all to help other families going through grief. She called me a few years ago when she was thinking of writing her book and I'm so grateful for our conversations and that our conversations may have helped her get it out there into a world where it's so needed. But we need Michelle here to talk about grief. More about talking to Michelle about the book).   Please, write the book, ride the bike, do the ironman, follow your heart and your dreams.  All of these incredible people gone too soon. https://www.breakthrought1d.org/news-and-updates/breakthrough-t1d-mourns-tragic-sudden-loss-of-five-ride-champions/   Thanks for joining me..

November is Diabetes Awareness Month! In this episode of Moms of the Lou, Trina sits down with Caitlin Ladd, a contributing writer for St. Louis Mom since 2020. They discuss their shared experience with type one diabetes. Caitlin's husband was diagnosed with type one diabetes at 17, and their son, Harrison, was diagnosed at 2.5 years old. Caitlin emphasizes the importance of mental health and community support, particularly through organizations like JDRF. She details the daily challenges of managing Harrison's diabetes, including balancing blood sugars, packing supplies, and dealing with the anxiety and responsibility it brings. Check out Caitlin's blog post to learn more about type one diabetes.Caitlin Ladd is mom to two boys, Harrison (2014) and Anderson (2019) and wife to George living in St. Charles, Mo. A St. Louis transplant who came to the area for college and never left, Caitlin is continuously busy exploring community philanthropic and cultural diversity efforts which has truly made St. Louis her hometown. As a working mom, she's eager to discuss balance, embracing a full life in this mommin' season and what it means to “have it all.” With that, she tries to layer in opportunities for self-care, sanity checks, some Shiraz and most importantly, SLEEP as a mom of two littles.We hope you enjoyed this podcast episode! To learn more about Moms of the Lou you can go to stlouismom.com or follow us on Instagram and Facebook. You can listen to the podcast on Apple Podcast and Spotify. And don't forget to rate and review so more people can tune in! This episode was produced by the St. Louis Mom. It was recorded and edited by Half Coast Studios in St. Louis, Missouri. Music composed by Trina Harger.

Today in Lighting is brought to you by ams OSRAM and their full color spectrum LEDs for precise tuning and ultimate customizability. Highlights today include: NY Controlled Conference 2024: A Step Up, Satco at NYControlled, JDRF at NYControlled, Lightapalooza 2025 Overview, WAC Lighting Appoints Stefan Bittner as VP of International Sales.

Pam Morrisroe, chief marketing officer of Breakthrough T1D (formerly JDRF), tells Jack O'Brien the backstory behind this storied brand's repositioning, and how the new name is resonating among the adult diabetes population.And for our Trends segment, we discuss the developing case of activist investor Starboard Value and its recent $1-billion stake in Pfizer.Music by Sixième Son Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Hopefully coming to Erik's JDRF walk this weekend! Also this hour, MPS messed up (again) and kids are paying the price. A Bucks venue announcement preview, and campaigns' ground game making a push this election season more than ever before (pre 1960)

Earlier this year, it looked like a big win for parents of kids with diabetes when the DOJ ruled that CGM can be considered standard of care.  Unfortunately, the lawyers fighting for families in this case tell me it's not that simple, the Dept of Justice ruling may have to be litigated on the local levels across the country. They're back to talk to me about what happened, what you need to know, and how you can make your issue known, if your child's school is giving you a hard time about continuous glucose monitoring. Our guests this week are Bonnie Roswig, an attorney with a small non profit legal center for children's advocacy focuses on addressing legal needs of vulnerable children and Jonathan Chapel was diagnosed with type 1 as an adult in 1999. He's a private practice lawyer in CT and is a past president of his local JDRF chapter. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. From my guests: "Parents should feel comfortable reaching out to us. (Jonathan Chappell (jchappell@fpglawct.com  or Bonnie Roswig – broswig@cca-ct.org) All information is confidential and there is no charge for our assistance." Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

Not only that he was late, but what he was late for that makes it almost unbelievable. This hour of Wisconsin's' Morning News includes a look at how Hurricane's affect insurance rates nationwide, waterspouts over Lake Michigan, The JDRF walk is this Saturday, and the Packers roll the Cardinals at Lambeau

Another really cool Breakthrough T1D piece put together by Erik Bilstad. Highlighting a young athlete who was just diagnosed with T1D. Erik speaks with Morgan & her mom and what its like to get that diagnosis. The JDRF walk is hosted by Erik this Saturday in Greenfield Park!

Even the strongest athletes need a game plan. This week, we dive into the world of endurance sports and type 1 diabetes with Dr. Anne Marie MacDonald, a marathon runner and Ironman triathlete who's been navigating the condition for over 35 years. From nutrition to insulin management, she shares how she juggles the demands of high-intensity training while managing her health. Plus, we explore the latest research on diabetes treatments that could reshape the future. In the wrap up Jer tackles a shocking medical story about an 84-year-old doctor, a botched colonoscopy, and how a simple failure to wear hearing aids spiraled into a disastrous outcome for the patient.Tune in to our other fascinating conversations about Type I diabetes here, here and here.Catch the full video version of this episode on YouTube!Follow Sickboy on Instagram, TikTok and Discord

Even the strongest athletes need a game plan. This week, we dive into the world of endurance sports and type 1 diabetes with Dr. Anne Marie MacDonald, a marathon runner and Ironman triathlete who's been navigating the condition for over 35 years. From nutrition to insulin management, she shares how she juggles the demands of high-intensity training while managing her health. Plus, we explore the latest research on diabetes treatments that could reshape the future. In the wrap up Jer tackles a shocking medical story about an 84-year-old doctor, a botched colonoscopy, and how a simple failure to wear hearing aids spiraled into a disastrous outcome for the patient.Tune in to our other fascinating conversations about Type I diabetes here, here and here.Catch the full video version of this episode on YouTube!Follow Sickboy on Instagram, TikTok and Discord

Welcome to Chatter with BNC, Business North Carolina's weekly podcast, serving up interviews with some of the Tar Heel State's most interesting people. Today's episode features an interview with Jessica Graham, CEO of Fionix Consulting. Graham is a leader in her profession and her community. She received her accreditation in public relations in 2003 and was named to the Public Relations Society of America College of Fellows in 2019. Jessica has been an active volunteer in the Public Relations Society of America Charlotte Chapter, Southeast District, and nationally. Locally, she's served on the boards of and volunteered with organizations like Dress for Success Charlotte, Charlotte's Trail of History, American Lung Association NC, Women Executives of Charlotte, JDRF, Classroom Central,  Leadership North Carolina and Leadership Charlotte.

A Sit Down with Breakthrough T1D (Formerly JDRF) – Featuring Aaron Kowalski, CEOTAKING CONTROL OF YOUR DIABETES® - THE PODCAST! ...With Expert Endocrinologists Living with T1D, Drs. Steven V. Edelman & Jeremy PettusIn this special edition of the Taking Control of Your Diabetes podcast, hosts Dr. Jeremy Pettus and Dr. Steve Edelman, both endocrinologists living with type 1 diabetes, interview Aaron Kowalski, CEO of Breakthrough T1D (formerly JDRF). They discuss recent research breakthroughs in type 1 diabetes, focusing on three main areas: improving lives through technology and medications, disease-modifying therapies to address the autoimmune nature of type 1 diabetes, and cellular replacement therapies. The conversation highlights advancements in hybrid closed-loop systems, emerging drugs for better glucose control, screening for early detection, and promising stem cell research that could lead to a cure. Aaron Kowalski expresses optimism about the future, suggesting that cell therapy products could be available within this decade, potentially allowing some people with type 1 diabetes to stop using insulin pumps.Key topics:How did Aaron Kowalski become the CEO of Breakthrough T1D?Who is Aaron Kowalski?What is the history of JDRF, and why did the name change?What does Breakthrough Specialize in?What is the mission of Breakthrough T1D?What are the three main types of goals/research at Breakthrough T1D?Improving the lives of those with type 1 diabetesDisease-modifying therapiesСell replacement therapiesWhat is the importance of getting screened for T1D?How has technology for diabetes evolved?Will there ever be a cure for type 1 diabetes?How can cellular replacement therapies help us find a cure for T1D?Breakthrough T1D (formerly JDRF) accelerates life-changing breakthroughs for type 1 diabetes through multiple approaches. They fund and drive research in three main areas: improving daily life with diabetes through technology and medication advancements, developing disease-modifying therapies to address the autoimmune nature of type 1 diabetes, and advancing cell replacement therapies, particularly stem cell-derived islet cells. Additionally, they focus on screening initiatives to identify at-risk individuals, advocate for broader access to treatments and clinical trials, educate the community and healthcare providers about new developments, and partner with pharmaceutical companies and research institutions. Their overarching goal is to drive towards curing type 1 diabetes while simultaneously making everyday life easier for those living with the condition.Follow Breakthrough T1D:Instagram: https://www.instagram.com/breakthrought1dhq/Facebook: https://www.facebook.com/breakthrought1dhqX: https://x.com/BreakthroughT1DLinkedin: https://www.linkedin.com/company/breakthrought1d/posts/?feedView=allVisit Breakthrough T1D Website: https://www.breakthrought1d.org/Connect with Aaron Kowalski, CEO of Breakthrough T1D: https://www.linkedin.com/in/aaron-kowalski-3221a35/Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: https://tcoyd.org/**Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook: https://www.facebook.com/TCOYD/Instagram: https://www.instagram.com/tcoyd/Video about YouTube:  https://www.youtube.com/channel/UC4WWhIDg18gP9ZC-IeqmYNQUseful links to discover: https://tcoydthepodcast.transistor.fm/55https://tcoyd.org/2024/06/an-endocrinologists-journey-helping-with-people-living-with-type-1-diabetes/ ★ Support this podcast ★

Pam Morrisroe is the CMO of Breakthrough T1D, formerly JDRF (Juvenile Diabetes Research Foundation). She holds a Bachelor of Science in Consumer Studies from the University of Vermont and an MBA in Marketing and Media Communication from Fordham University. With over 20 years of marketing experience, Pam has led award-winning campaigns for clients like Ford, American Express, and Volkswagen across multiple channels, including digital activation, experiential, branding, consumer, business-to-business, CRM and omnichannel commerce. As Managing Director at VMLY&R, she spearheaded innovative virtual programming during the pandemic, driving significant growth. Now at Breakthrough T1D, Pam leads campaigns to raise awareness of type 1 diabetes and support the organization's mission to create a world without T1D.Breakthrough T1D, formerly JDRF, is a nonprofit organization founded in 1970 by families affected by type 1 diabetes (T1D). It is now the leading global research and advocacy organization for T1D. Its mission is to accelerate life changing breakthroughs to prevent, cure, and treat T1D and its complications by connecting the brightest minds to advance treatments, influence policy, and improve access to care.On today's show, Alan and Pam discuss what sparked the rebranding from JDRF to Breakthrough T1D. They delve into the research behind the rebrand, the careful selection of the new name, and how it has been seamlessly integrated into their marketing strategy. They also highlight the progress made, what's working well, and other critical milestones essential for rebranding success. Additionally, Pam highlights the importance of diversifying knowledge across various marketing categories, explaining how this approach has contributed to her expertise and success in the field. In this episode, you'll learn: Why research is critical to a successful rebrandHow to effectively integrate a rebrand into every aspect of your companyThe strategic, intentional steps behind a successful rebranding campaign, and how it expands consumer reachKey Highlights: [02:14] Experience of dropping your oldest son off at college[03:15] Living the only child life[04:10] Pam's career path[06:50] What is Breakthrough T1D[08:22] What sparked the rebrand[10:30] Critical milestones to rebranding[13:51] How you knew you had the right name[16:40] Why simplicity was so important in the pitch process[18:00] How does the rebrand manifest in the marketing[22:03] Lessons learned[25:42] Experience of your past that defines you[27:13] Advice to younger self[29:05] A topic that you and other marketers need to learn more about[30:05] Trends or subcultures others should follow[32:36] Largest opportunity or threat to marketers todayLooking for more?Visit our website for the full show notes, links to resources mentioned in this episode, and ways to connect with the guest! Become a member today and listen ad-free, visit https://plus.acast.com/s/marketingtoday. Hosted on Acast. See acast.com/privacy for more information.

Meet Pam. She's the Chief Marketing Officer at Breakthrough T1D (formerly JDRF). She's here to share the inside scoop on their nearly two-year rebranding journey, driven by deep research

34-year-old Jonty Brown is a humble Yorkshire man who went out for a little jog in lockdown… and ended up changing his entire life.He quickly hit marathon distances, and then Ultra Marathon distances - becoming the first person with type 1 diabetes to run across the UK. Jonty's now an Adidas running coach and co-founder of of Runlimited, a London running community on a mission to create the most collaborative and inclusive running collective on the planet.Jonty has used his talent to raise awareness for type 1 diabetes, as a way to give back to the healthcare team that looked after him so well after his diagnosis aged 12. Along with his family, they were a huge support when he was diagnosed with diabetes-related depression and anxiety as a teenager. In 2023 Jonty ran 102km around his beloved Victoria Park in Hackney to raise money for JDRF, celebrating the 102nd anniversary of the discovery of insulin. Jonty chats about his whirlwind journey since 2020, how he credits diabetes technology for taking his running to the next level, his advice for both shorter and longer runs with diabetes, and asking his mates to inject him at school.Jonty is such a likeable guy doing incredible things; even if you're not a runner, this is definitely an episode to dive into. CONNECT WITH JONTY: Follow Jonty on Instagram. Follow Runlimited on Instagram. Find out more about Runlimited. JOIN THE TYPE 1 ON 1 COMMUNITYWe've got an Instagram account! Come and say hi @studiotype1on1. SPONSOR MESSAGE:Thanks to my episode sponsors Dexcom.Pioneer and leader in Real-Time continuous glucose monitors, Dexcom's goal is to simplify and improve diabetes management for every possible person with diabetes. They have a choice of systems, so you can find the right one for your lifestyle at https://www.dexcom.com/

Why Everyone Should Screen for Type 1 – Featuring Anastasia Albanese-O'Neill, PhD, APRN, CDCES,Associate Vice President of Type 1 Diabetes Education 7 Clinical Implementation, with a focus on accelerating progress towards a cure; JDRF International.TAKING CONTROL OF YOUR DIABETES® - THE PODCAST! ...With Expert Endocrinologists Living with T1D, Drs. Steven V. Edelman & Jeremy PettusIn this episode of the Taking Control of Your Diabetes podcast, Dr. Steve Edelman is joined by a passionate advocate and expert in diabetes education, Anastasia Albanese O'Neil PhD, APRN, CDCES, the Associate Vice President of Type 1 Diabetes Education and Clinical Implementation at Breakthrough T1D International (former JDRF). As a mother of a child with type 1 diabetes, she brings both professional expertise and personal experience to the conversation. Together, they delve into the critical topic of screening for type 1 diabetes, exploring its importance and the benefits it offers to individuals and families.In this episode, we will talk about:Anastasia's journey and motivation in diabetes advocacy and researchThe significance of early detection and screening for type 1 diabetesHow screening can prevent diabetic ketoacidosis (DKA)The role of family members in screening and why their involvement is crucialRecent advancements in diabetes research and the impact of new FDA-approved therapiesThe importance of immunosuppression in diabetes treatmentCurrent methods and guidelines for screening and confirming type 1 diabetesPractical steps and resources for getting screened, including TrialNet and the ASK studyOvercoming barriers to screening in primary care settingsThe future of diabetes care and the push towards universal screeningScreen for Type 1 Diabetes: This resource provides information about screening for type 1 diabetes and available screening pathways: https://www.screenfortype1.com/TrialNet: A clinical study that offers free screening for type 1 diabetes to family members of individuals with the condition: https://www.trialnet.orgASK Study: This study screens children in the United States for type 1 diabetes and celiac disease using the same blood sample: https://www.askhealth.orgAmerican Diabetes Association Standards of Care: Information about the delay and prevention of diabetes, including type 1 diabetes: https://diabetesjournals.org/care/issue/47/Supplement_1FDA Approval of Teplizumab: Details about the FDA approval of the medication Teplizumab (TZIELD), which can delay the onset of type 1 diabetes: https://www.fda.gov/media/164864/download**Tune in for 2 new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!** ★ Support this podcast ★

This week, the lads discuss the importance of mental health and share their personal wins and struggles. Mike opens up about his journey to improve his mindset and how a simple quote has transformed his daily routine. Meanwhile, Jack celebrates three consecutive nights of stable glucose levels, despite indulging in some cheat meals. They also dive into the challenges of resisting tempting foods at work and the significance of sleep in diabetes management. 00:00 - Sometimes you have to make believe to enjoy life 03:55 - So, mister non grumpy pants, what is your win this week 06:19 - What's your struggle this week, Jack? 09:54 - Sleep is so, uh, important. You want to be sleeping at least 7 hours a night 16:52 - I don't fatigue at all until lunchtime, unless I'm working hard 18:31 - Jack says he ate everything late and stayed in range over the weekend 21:59 - All we need to do if we fancy takeaways is have a small dinner 25:36 - I read the back of the packet, Jack 29:01 - Apple and peanut butter before bed if I'm lowish 29:16 - Listener Wins 29:29 - Melissa Linstead got her takeaway count to nine this week 32:18 - Cycling 652 miles from home to euros for JDRF 37:11 - Amber's suprise win 39:11 - Outro As always, the episode is filled with laughs, relatable moments, and valuable insights into living with Type 1 Diabetes. Join the conversation and share your stories with the T1D community. Don't forget to rate, review, and subscribe to help others find the podcast. Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Share your stories at https://wearet1d.com New episodes are released every Sunday & Wednesday PS. If you would like to be a Guest on the podcast, please go to the website https://wearet1d.com/guest-booking and fill out the form. Also, don't forget to vote for us in the British Podcast Awards! Your support means the world to us. Visit https://www.britishpodcastawards.com/voting, search for "We Are T1D," and cast your vote. Thank you!  

Alexi Melvin is making significant strides in the Broadway community as a producer in shows like "Here Lies Love," "The Outsiders," and "The Notebook". She highlights the struggle of balancing commercial success with artistic bravery, advocating for more support for innovative and risk-taking productions. Growing up with a professional baseball playing dad, she looks back on her journey to finding her calling, how she developed a love for the arts thanks to her mom, and the unwavering support she got from both parents along the way. With almost 100k followers on TikTok, she reflects on her experience with social media, transitioning from queer relatable content to theater-focused posts, and how her audience has positively received this shift. She also delves into the role of social media in modern theater marketing, and how shows like "The Outsiders" leverage platforms like TikTok to reach more audiences. As more and more shows feature queer stories and diverse casting like "The Notebook" and "Illinois", she stresses the need for more queer representation on stage and the challenges of achieving this in an industry dominated by big-budget musicals. Alexi opens up about her journey with pronouns and gender identity, sharing her transition from they/them to she/they and the importance of creating a safe environment for self-exploration. Whether it's producing or posting on social media, she encourages aspirants to channel their “fan girl energy” and not shy away from doing what you're a fan of. Alexi Melvin is a multi-Tony Award-nominated Broadway producer for her work on “Illinois” and “The Outsiders”. She has also done work on the producing teams of “Here Lies Love” and “The Notebook”. A writer and actor who takes the term multi-hyphenate to an all-new level, she is a proud member of and advocate for the LGBTQ-plus community and is deeply involved with type one diabetes organizations such as JDRF and Beyond Type 1. She has notable voice work in “Rogue One: A Star Wars Story” and “Star Wars: The Last Jedi”, onscreen appearances in “Time Out of Mind”, and “Quarter”, and a significant presence as an LGBTQ-plus creator on TikTok with almost 100,000 followers. Connect with Alexi: TikTok: @theonlylex Instagram: @thealexijames Connect with The Theatre Podcast: Support the podcast on Patreon: Patreon.com/TheTheatrePodcast YouTube: YouTube.com/TheTheatrePodcast Threads, Twitter & Instagram: @theatre_podcast TikTok: @thetheatrepodcast Facebook.com/OfficialTheatrePodcast TheTheatrePodcast.com My personal Instagram: @alanseales Learn more about your ad choices. Visit megaphone.fm/adchoices

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The Eversense CGM could soon be approved for one year of continuous use, the first generic GLP-1 medication is launched, a new company tauts and all-in-one sensor and pump infusion set, a new diabetes accessory in the Roblox game, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX The first ever generic GLP-1 medication will soon be available in the US. It's a generic of Victoza, originally approved by the FDA in 2010 for diabetes, is part of the same class of drugs that includes Ozempic and Mounjaro. Liraglutide is Glucagon-like peptide-1 receptor agonists (otherwise known as GLP-1s or GLP-1 RAs) are a class of incretin drugs that mimic the body's natural hormones to help treat diabetes and obesity. However, the popularity of the drugs has spiraled out of control at times, leading to shortages and supply chain issues in the US and abroad.  The arrival of a GLP-1 generic drug provides reasons to be hopeful for doctors and patients alike, but there are also caveats. Couple of caveats - liraglutide is injected once daily (vs. weekly) and many doctors say it doesn't work as well for as many people as semaglutide and terzepatide. No confirmation on the price Two other generic options are being developed and could launch in December 2024. Patents for newer GLP-1 medications like Ozempic and Wegovy won't expire until several years down the road https://www.healthline.com/health-news/victoza-generic-glp1-drug-available XX Senseonics plans to launch a 365-day sensor in the U.S. in the fourth quarter of this year. A one-year Eversense CGM could be a game changer for the company.   In 2024, Senseonics expects to more than double U.S. new patient starts and increase the global installed base by around 50%. The growth is built on the current 180-day version of Senseonics' implantable Eversense CGM. Eversense's 180-day sensor can need calibrating twice a day, something Senseonics CEO Tim Goodnow said “has been a competitive disadvantage.” Users calibrate the 365-day sensor once a week. Senseonics is in talks with insulin pump manufacturers about integrating its Eversense CGM with their devices but has yet to commit to a timeline for finalizing an agreement. https://www.medtechdive.com/news/senseonics-365-day-cgm-2025-sales/719717/ XX People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, doctors say it shouldn't deter patients from using the medicines to treat diabetes or obesity.   Last summer, doctors at Mass Eye and Ear noticed an unusually high number of patients with non-arteritic anterior ischemic optic neuropathy, or NAION, a type of eye stroke that causes sudden, painless vision loss in one eye.   The condition is relatively rare — up to 10 out of 100,000 people in the general population may experience it — but the doctors noted three cases in one week, and each of those patients was taking semaglutide medications. The risk was found to be greatest within the first year of receiving a prescription for semaglutide.   The study, published Wednesday in the medical journal JAMA Ophthalmology, cannot prove that semaglutide medications cause NAION. And the small number of patients — an average of about 100 cases were identified each year — from one specialized medical center may not apply to a broader population. The ways that semaglutides interact with the eyes are not entirely understood. And the exact cause of NAION is not known either. The condition causes damage to the optic nerve, but there is often no warning before vision loss.   For now, patients who are taking semaglutide or considering treatment should discuss the risks and benefits with their doctors, especially those who have other known optic nerve problems such as glaucoma or preexisting visual loss, experts say https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-ozempic-linked-with-sight-threatening-eye-disorder-study-2024-07-03/ XX We got some updates at ADA about the over the counter CGMS Dexcom Stelo and Abbot's Libre. Dexom plans a late august launch of stelo, which you'll order from their website – it won't be physically in stores. Abbott also plans to sell its wellness-oriented Lingo device this summer through an e-commerce website. That's a sensor that's been available in other coutnires for a while, but was recently okayed in the US. It's not meant for people with diabetes. The Libre Rio is designed or adulst with type 2 who don't use insulin. No timing yet on that product's launch. Neither Abbott nor Dexcom have disclosed pricing for the upcoming products. https://www.medtechdive.com/news/abbott-dexcom-over-the-counter-cgm-launch/719928/ XX Insulet is looking to expand the label for its Omnipod 5 insulin pump for people with Type 2 diabetes. The company said Friday it recently filed with the Food and Drug Administration. Insulet presented study results at the American Diabetes Association's 84th Scientific Sessions that evaluated Omnipod 5 in people with Type 2 diabetes who were taking basal insulin or multiple daily injections. The results showed “substantial improvements in blood glucose outcomes and overall quality of life,” said study chair Francisco Pasquel, an associate professor of endocrinology at Emory School of Medicine. Omnipod 5 is currently cleared in the U.S. for people with Type 1 diabetes. Insulet hopes to expand the pump to people with Type 2 diabetes, with an expected launch in early 2025. The FDA has not yet cleared any automated insulin delivery systems for people with Type 2 diabetes, Insulet said. The company has a basal-only insulin pump, called Omnipod Go, that was cleared for people with Type 2 diabetes last year, but it does not connect to other devices. Even though Omnipod 5 is not currently indicated for Type 2 diabetes, doctors prescribe it for their patients with full reimbursement since the pharmacy channel doesn't distinguish between Type 1 or Type 2 patients, J.P. Morgan analyst Robbie Marcus wrote in a research note on Sunday. https://www.medtechdive.com/news/insulet-omnipod-5-type-2-diabetes-study/719644/ XX In the keynote address at the American Diabetes Association annual conference, FDA Commissioner Dr. Robert Califf expressed concerns about the rising rates of diabetes in the U.S. Though revolutionary medications and technologies for diabetes and weight loss continue to emerge, these treatments are vastly underused. The silver lining lies with type 1 diabetes therapies, which are showing great promise in clinical trials. “For the larger epidemic of type 2 diabetes, we're failing right now,” Califf said. “I don't say that lightly.” A huge problem, Califf said, is access. While most health insurance plans cover medical devices and medications for diabetes, without insurance, costs add up quickly. Ozempic, for example, costs nearly $1,000 per month without insurance. Studies have found that regardless of insurance status, roughly 26% of Americans skipped or delayed treatment due to cost. https://diatribe.org/diabetes-management/fda-commissioner-says-were-failing-people-type-2-diabetes XX Embecta presented two abstracts at the American Diabetes Association Scientific Sessions last weekend making the case for its insulin patch pump for Type 2 diabetes. The company submitted the device for Food and Drug Administration clearance in late 2023. The diabetes device company developed a patch pump with a larger insulin reservoir that can hold up to 300 units. Embecta, which is better known for making equipment such as pen needles and insulin syringes, has been developing its first patch pump. The company found that a device with a larger insulin reservoir could provide longer wear times and fewer disposable patches. https://www.medtechdive.com/news/embecta-insulin-patch-pump-volume-american-diabetes-association/719779/ XX   Pump/CGM sensor in one The niaa signature patch pump, shown with a watch displaying current blood sugar level The niaa signature patch pump has a manual bolus button and is part of an in-development AID system. Swiss technology maker Pharmasens demonstrated a new semi-reusable tubeless patch pump and glucose sensor in the same compact device, called the niia signature, which the company says can be worn for five days.   The top of the device, which includes Bluetooth connectivity and the electronic and mechanical parts to control the pump, separates from the disposable 300-unit reservoir along with the adhesive used to attach the device to the body via a steel cannula. A small button on the device allows manual bolusing. The company says an AID system will manage the device, controlled by smartphone.   PharmaSens' simpler basal-bolus patch pump, the niia essential, was submitted for FDA approval in late December. Availability of the niia signature AID system has yet to be announced. https://diatribe.org/diabetes-technology/diabetes-technology-display-ada-2024 XX Edgepark Commercial XX New international consensus statement offers guidance on the care and monitoring of people who are at high risk for type 1 diabetes (T1D). This is all about screening and testing for islet autoantibodies. These individuals are classified as: At risk or Stage 0 (single autoantibody or transient single autoantibody), Stage 1 (two or more autoantibodies with normoglycemia), and Stage 2 (two or more autoantibodies with dysglycemia but without symptoms and not yet meeting diagnostic criteria for Stage 3 clinical T1D). The document was presented on June 24, 2024 in a 90-minute symposium at the American Diabetes Association's annual Scientific Sessions and published simultaneously in both Diabetes Care and Diabetologia. "This is not guidance around who to screen or when to screen. This is guidance for the hundreds of thousands of people around the world who have participated in screening, mostly through research programs, and have been identified with positive autoantibodies and need care in the clinical setting," panel co-chair Anastasia Albanese-O'Neill, PhD, APRN, CDCES, of Breakthrough T1D, told Medscape Medical News.   The recommendations also include when to start insulin, and how to provide education and psychosocial support to individuals and family members of those given the early-stage T1D diagnosis. https://www.medscape.com/viewarticle/experts-advise-early-risk-monitoring-type-1-diabetes-2024a1000bpo XX Roblox has added a diabetic option, complete with insuli pen and Dexcom You can find it in the marketplace JDRF – now breakthrough t1d – started a world in roblox a couple of years ago as well Roblox is a super popular online game that a lot of kids play. https://www.roblox.com/games/5823990610/Breakthrough-T1D-World XX FFL next week! Join us again soon!

In this episode, we speak with the Co-Founder and CEO of Armada, Dan Wright. Armada is the world's first full-stack edge computing platform, revolutionizing connectivity, compute, and AI solutions. Armada enables companies to rapidly deploy, operate and monitor a complete modular data center to the remote corners of the world. Before Armada, Dan was the CEO of DataRobot and COO of AppDynamics. He is invested in the future of technology as an investor, advisor, and board member for various visionary startups, including Abnormal Security, Avi Networks (acquired by VMware), and Embrace. Dan is a Board Member of JDRF. To learn more about this organization click here. I am your host RJ Lumba.  We hope you enjoy the show.  If you like the episode click to follow.

In this episode, we dive into a listener's unforgettable and hilarious hypo experience on a sunny beach in Spain. Get ready to laugh out loud as we share the outtakes and mishaps from sundays episode, and unexpected twists of managing type 1 diabetes under the Spanish sun. OMG This is not to be missed!! As always, the episode is filled with laughs, relatable moments, and valuable insights into living with Type 1 Diabetes. Join the conversation and share your stories with the T1D community. Don't forget to rate, review, and subscribe to help others find the podcast. Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Share your stories at https://wearet1d.com New episodes are released every Sunday & Wednesday PS. If you would like to be a Guest on the podcast, please go to the website https://wearet1d.com/guest-booking and fill out the form. Also, don't forget to vote for us in the British Podcast Awards! Your support means the world to us. Visit https://www.britishpodcastawards.com/voting, search for "We Are T1D," and cast your vote. Thank you!      

David Roberts is the President and Chief Executive Officer of Verra Mobility, a leading provider of smart mobility technology solutions. Verra Mobility provides hardware, software and services to a wide customer base including rental car companies, fleet management companies, cities, school districts and universities. The company's total revenue in 2023 was $817 million and has more than 1,500 employees around the world. Verra Mobility is headquartered in Mesa, Arizona.Before joining Verra Mobility in August 2014, David held several senior leadership roles with technology and finance companies. He was the President and Chief Executive Officer of BillingTree, a multi-channel electronic payment platform company serving insurance, utilities and healthcare customers. He was also a Managing Director at Bank of AmericaMerrill Lynch, leading the Equity Plan Services business.David's leadership philosophy is reflective and personal, focused on the principles of "servant leadership" and "unselfing yourself” as a leader, with humility and a focus on putting others first. He prioritizes promoting selfless leadership, adapting to change, and building empowered teams. This leadership philosophy is effective in delivering results and cultivating a winning culture. David values the well-being of his employees and the success of the organization over personal gains, fostering a culture of trust and loyalty. David encourages his direct reports to take initiative and ownership of their work. His leadership style can best be summarized with the acronym F.C.A. – maintaining a Focus on goals, championing Clarity in communication and responsibilities, and ensuring Accountability throughout the organization. David started his career in management consulting with a focus on innovation. He earned his MBA from the University of Chicago and his bachelor's degree from Baylor University in Texas.David has a passion for volunteer work for organizations that specialize in supporting children. He has served as an advisor for Feed My Starving Children for more than 10 years and is an active volunteer and fundraiser for JDRF, a leading organization dedicated to funding research for diabetes. David lives with his family in Scottsdale, Arizona, with his wife and four children. David is a thought leader who can explain emerging trends in transportation, smart cities and leadership in an engaging, understandable and vision-driven way, while still keeping things grounded and practical. Hosted on Acast. See acast.com/privacy for more information.

When it comes to diabetes advocates, few are held in such regard as Renza Scibilia. And rightly so, as for more than two decades she has travelled the world to ensure the voices of people with diabetes are not only acknowledged, but listened to and understood by everyone from world-renowned healthcare professionals to pharmaceutical bosses. Diagnosed in 1998, Renza's activism started out through the Diabetonic blog, published from her desk at home in Melbourne, Australia. But such is her determination and motivation to create meaningful change, she is now Director of Community Building & Communications at Breakthrough T1D (formerly JDRF), Head of Advocacy at #dedoc°, and in her spare time (when she's not baking or on a plane), she runs a health consultancy. As much as Renza works hard to makes sure she has a seat at the table, she works even harder to ensure that there are seats for the rest of us too, shaping outcomes for everyone who has been forced through lived experience to cruelly understand what it really means to live with type 1 diabetes.  'When insulin has been around for 100 years, lack of access should not be happening,' she told me. 'It's perfectly ok to feel overwhelmed by the personal burden of type 1 diabetes and what we are living with, but I do also feel the weight of what type 1 diabetes is on a bigger scale. Sometimes I think it's ok to feel hopeless because of that, because in many ways it's what drives me.' This generous and heartfelt conversation is such a treat, and a reminder of the power we collectively have for change when the right people are shaping the conversation. CONNECT WITH RENZA:Take a look at Renza's blog, Diabetogenic. Follow Renza on X.JOIN THE TYPE 1 ON 1 COMMUNITYWe've got an Instagram account! Come and say hi @studiotype1on1. SPONSOR MESSAGE: Thanks to my episode sponsors Dexcom. Pioneer and leader in Real-Time continuous glucose monitors, Dexcom's goal is to simplify and improve diabetes management for every possible person with diabetes. They have a choice of systems, so you can find the right one for your lifestyle at https://www.dexcom.com/

Send us a Text Message.What if mastering the art of authenticity could transform your life and career? Join us as we sit down with the extraordinary Samantha Redden, a powerhouse of talents who seamlessly juggles roles as a podcast host, senior master instructor for Cycle Bar, type 1 diabetes advocate, and motivational speaker. Samantha shares her inspiring journey, from preparing for the Mrs. Ohio America pageant to her reflections on slam poetry, a passion inherited from her poet mother. Be captivated by her anecdotes about unique pageant talents and her heartfelt advice on building confidence and self-esteem for young girls.Discover how Samantha overcomes challenges and builds resilience through her work at Cycle Bar and her podcast, "The Samantha Show." Learn how these pursuits have positively influenced her family dynamics, especially her daughter's outlook on dreaming big and chasing goals. Samantha offers practical techniques—such as positive affirmations and visualization—that help manage nerves and stress. Gain valuable insights from her therapist friend on handling pre-event anxiety, making this episode a treasure trove of practical advice on maintaining mental well-being.On a lighter note, enjoy some whimsical moments as Samantha answers random questions and shares personal stories, including fun hypotheticals like who would play her in a movie. Get to know her quirky husband Joe and his extraordinary napping skills, and learn more about Samantha's podcast, which features engaging interviews and charming banter. Don't miss out on this enriching episode filled with laughter, wisdom, and the mantra: vision, relate, develop. Tune in and be inspired by Samantha's journey and the transformative power of authenticity.Connect with Passing The Torch: Facebook and IG: @torchmartin More Amazing Stories: Episode 28: Purple Heart Recipient CMSgt Ben Seekell – Your Capacity is Limitless Episode 31: Todd Henry – Choose To Be Brave Episode 35: Brook Cupps – Shaping Leaders On and Off The Court Episode 41: Lee Ellis – Freeing You From Bond That Make You Insecure

JDRF… is no more. A rebranding and name change means the organization founded in 1970 by concerned parents will now be known as Breakthrough T1D. You can guess some of the reasons for this change – the “J” for juvenile has long been a turn off for adults living with type 1 – but some of the other reasons are surprising. We'll do a deep dive into what this means for the community, the fund raising and research, and the organization itself. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Stacey's webinar with Breakthrough T1D Mountain West Chapter The Breakthrough T1D announcement video  Find out more about Moms' Night Out - registration is open for Denver and Philadelphia! Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom goes Direct to Watch in the US, Abbott gets FDA okay for its OTC CGM, new study about metformin during pregnancy, an update on semaglutides, JDRF changes its name, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX Our top story this week – some CGM news… Dexcom announces Direct to Watch is here in the US. From the release: Using its own dedicated Bluetooth connection, Dexcom G7 sends glucose information and personalized alerts right to a user's Apple Watch. Dexcom G7 is the only CGM system that can display glucose on multiple devices simultaneously and independently, including on a smartphone, smart watch, receiver or connected automated insulin delivery system.‡ Apple products are built with strong privacy protections and users have control over their data in the Health app. (If you like to keep track of these things, we are just over 7 years since the official announcement this was going to happen) XX FDA approves Abbot's over-the-counter continuous glucose monitoring system. It's called Lingo and comes a couple of months after Dexcom won clearance for its Stelo over-the-counter CGM. Abbott has been selling Lingo in the UK as more of a lifestyle device – not aimed at people with diabetes. They call it a consumer biowearable designed to help people make decisions about their overall health and wellness; Lingo is not intended for use in diagnosis, treatment or management of a disease or medical condition. No word yet on exactly what kind of app they'll launch here in the US or if it will be marketed toward people with diabetes like the Libre currently is.. just as an OTC option. While it seems like the same hardware, the company has not confirmed that. https://www.drugdeliverybusiness.com/abbott-wins-fda-clearance-for-its-lingo-otc-glucose-monitor/ XX New study looking at the use of continuous glucose monitors (CGMs by rural children and adolescents living with type 1 diabetes. Previous studies examining the use of CGMs by children relied on prescription records to identify use of these devices, but just because someone is prescribed a CGM does not mean that they use one; barriers such as cost can stand in the way. this study instead identified use of these devices according to billing codes for the interpretation of CGM readings by the provider. The results unearthed a sizeable disparity. Those living in rural areas were significantly less likely to use a CGM than those in urban areas, even after adjusting for sex, race or ethnicity and insurance type. Specifically, compared with youth living in urban areas, the use of CGMs was 31% lower for children and adolescents living in small rural towns, and 49% lower for those living in isolated rural towns. The gap between rural and urban patients persisted across the four years of the study, even as the use of CGMs increased for all patient types during this time. These results are also relevant to people with type 2 diabetes who require insulin, Tilden said. The results also revealed that non-White patients, those who had public insurance and patients who lived in areas with a higher NPI all were less likely to use CGMs. More research is needed to explore the reasons for these disparities, but Tilden said they likely are a function of such issues as cost, reduced internet access, which CGMs require to relay their data, and distance from clinics and Medicaid-contracted pharmacies.   The next step is figuring out how to eliminate those disparities. These researchers are seeking funding to design an intervention that uses telemedicine and partners with a network of 35 clinics across Kansas to deliver specialty care to diabetes patients in rural areas.   https://www.kumc.edu/about/news/news-archive/diabetes-monitoring-disparities.html XX Metformin is just as safe to use during pregnancy to treat type 2 diabetes as insulin. The study, which hasn't been published yet in a peer-reviewed journal, tracked health data and potential long-term side effects of using metformin during pregnancy for up to 11 years postpartum. While today's popular GLP-1 medications, such as Ozempic, are not approved yet for use during pregnancy, metformin and insulin have been used during pregnancy for decades. https://www.medicalnewstoday.com/articles/metformin-may-be-as-safe-as-insulin-to-treat-diabetes-during-pregnancy XX Once weekly basal insulin is a no go from an FDA advisory panel. They found the potential benefits of the investigational once-weekly basal insulin analog icodec (Novo Nordisk) don't outweigh the increased risk for hypoglycemia in people with type 1 diabetes. We've been following this for a long time. Most of the trials here have been in people with type 2 – and the FDA hasn't publicly raised concerns about efficacy and safety seen in any of those trials. But the type 1 trial found a significant increase in serious or severe hypoglycemia with icodec compared with degludec (4.66 vs 1.0 events per 100 patient-years; 14 events in nine patients versus three in three patients), with the greatest incidence in the icodec group on days 2-4 after injection. None of the events resulted in treatment discontinuation or study withdrawal. This doesn't mean the FDA can't approve the drug – and the panel mentioned that they hope the FDA would work with Novo Nordisk to – quote - make sure that if this is approved there are as many guardrails as possible to make sure we don't harm people with type 1 diabetes." https://www.medscape.com/viewarticle/advisory-panel-votes-against-once-weekly-insulin-type-1-2024a10009we XX The shortage of Ozempic and Mounjaro continues… with some doctors offering advice of what to do if you can't fill your prescription. Health care company Ro recently launched a public crowd-sourced shortage tracker to help patients. The company says they also share the patient-reported shortages to the FDA. Chae says some patients could discuss with their doctor off-label use of other medications, like liraglutide injections (such as Trulicity, for example), depending on their preexisting conditions. Patients may also consider trying compounded semaglutide. Compounded drugs are made to order in local pharmacies, but Chae says be wary of them: Because of their bespoke nature, the drugs' safety isn't regulated by the FDA. “The state of Mississippi, North Carolina and West Virginia have banned these compounded drugs,” he said. https://www.scrippsnews.com/health/popular-diet-and-diabetes-drugs-in-short-supply-as-demand-surges XX Commercial XX Big news from JDRF – they've changed their name to "Breakthrough T1D." Here's the statement: "Breakthrough T1D was selected following a rigorous, data-informed process because it more accurately conveys the nonprofit's ability to connect with and work on behalf of the entire type 1 diabetes community," The median age for a person living with T1D worldwide is 37 years. Only about one in five are aged 20 years or younger, two thirds are aged 20-64 years, and another one in five are aged 65 years or older.   The organization was founded in 1970 by parents of children with T1D and was originally called the "Juvenile Diabetes Foundation." The "research" part was added in 2012 to reflect that aspect of its mission. We will have much more on this next week – Tuesday's episode is an interview with JDRF. Oops with Breakthrough T1D. https://www.medscape.com/viewarticle/type-1-diabetes-group-grows-jdrf-now-breakthrough-t1d-2024a1000afr XX Android users – heads up! The FDA has approved a hybrid, closed-loop, insulin-delivery Android app. In May, CamDiab, revealed that the CamAPS FX had received approval. CamAPS FX is approved for people with type 1 diabetes who are two years of age or older, including those who are pregnant.   CamAPS FX works in unison with the FreeStyle Libre 3 and the Dexcom G6 to produce a hybrid, closed-loop system that is compatible with the Ypsomed mylife YpsoPump. The app and those pumps are already approved in several other countries. You may recall that the YspoPump had a partnership with Lilly to bring that pump to the US – but that deal died in 2022. Yspomed is still moving forward to get FDA approval for their pump. https://beyondtype1.org/fda-approves-camaps-fx-hybrid-closed-loop-insulin-delivery-app/?fbclid=IwZXh0bgNhZW0CMTEAAR137RhLAt2GfIJ_BBYMrhU2R-maQ0EQmwOFhPfKN9iCnG2BKWY6dEB0sTk_aem_ATLPk1xWOnLNzPz7LvYINbTdCVMZk7pcRmma2pgG5MIo0OfinomTSgjsTsTpW_fE6GNVRnScZS6UGzaTvP1SewNW XX Driven by payments for diabetes treatments — especially insulin — prescription drugs for metabolic diseases now make up nearly one quarter of total national pharmaceutical spending, reported a study of spending trends by therapeutic class. The detailed examination of a decade's worth of US drug spending also found changes in who pays for the medicines, with an overall drop in out-of-pocket costs, except in the metabolic disease category. The findings add to concerns about the costs of US diabetes treatments. Annual US spending on diabetes medicines surged from $27.2 billion in 2011 to $89.2 billion in 2020,  according to this paper was published online in Research in Social and Administrative Pharmacy. In the same period, total annual pharmaceutical spending rose at a far slower rate. Yet much of the persistent gain in the cost of diabetes treatments in this same period was due to a decades-old drug, insulin, a cornerstone of diabetes care. https://www.medscape.com/viewarticle/study-raises-concerns-about-rising-cost-diabetes-meds-2024a1000a8e XX The number of people aged over 16 with insulin-dependent diabetes and eating disorder symptoms is as high as one in four, a study has revealed. Researchers from the University of Eastern Finland examined the findings from 45 past studies, looking at data from almost 11,600 people with insulin-dependent diabetes. They say that understanding the extent of the issue is the first step in developing treatment pathways, citing Finland as an example of a country which does not have care pathways for people with both diabetes and eating disorders. Of course, neither does the US. Typical eating disorder symptoms include restricting food intake and binge eating. Symptoms particular to insulin-dependent diabetes include insulin omission, which is when individuals restrict or skip insulin doses due to fears of putting on weight. The prevalence of eating disorder symptoms was higher in women than in men, a finding previously made in young people too. The age of an individual was not found to be a factor, with eating disorders occurring regardless of age group. https://www.diabetes.co.uk/news/2024/jun/1-in-4-people-with-insulin-dependent-diabetes-have-eating-disorder-symptoms-research-shows.html XX Congrats to Kate Farnsworth who recently won Diabetes Action Canada Catalyst for Change award. Many of you know Kate from the early DIY days.. Kate Farnsworth is the patient partner co-lead for the Innovations in Type-1 Diabetes Program. Kate has been heavily involved in the Do-It-Yourself #wearenotwaiting movement since her daughter Sydney was diagnosed with type 1 diabetes at the age of 8. With a background in information technology and graphic design, Kate has lent her skillset to developing diabetes watch faces for remote monitoring used by patients worldwide. Kate has created an online patient-driven support community for people who are exploring DIY closed-loop solutions and continues to advocate for all people with diabetes to have access to the best tools to manage their diabetes. Very nice to see this award go to someone very well deserved. XX Join us again soon!

Physical activity and exercise is known to be beneficial for individuals with both Type 1 and Type 2 Diabetes. This podcast is another in the BJSM and PACC series which looks to help health care professionals who are looking to have more conversations with patients about physical activity in long term conditions.  Nusrat Kausar is a dietician who sits on the BDA specialist groups for Sports and Exercise Nutrition and Exercise in diabetes. She has a wealth of experience in discussion physical activity with this patient group and in providing education for others to do so. She joins Dr Dan Fitzpatrick, a Sport and Exercise Medicine Registrar, to discuss this crucial area. The Physical Activity Clinical Champions or PACC programme is a national project delivering physical activity education to professionals working in healthcare to help get patients more physically active. It was previously being led by public health England as part of the moving healthcare professionals programme and funded by the national lottery & Sport England and is now being led by a consortium of The Faculty of Sport and Exercise Medicine, The Advance Wellbeing Research Centre at Sheffield Hallam University and Intelligent Health and is being re-designed with new resources. This podcast forms part of a series to support physical activity education for professionals working in healthcare. For anyone you would like to get involved with PACC project then please do email us at pacc@shu.ac.uk  Resources discussed https://movingmedicine.ac.uk/pacc/   Type 1 -  Digibete - https://www.digibete.org/sports-page/ Team Type One Style - https://teamtypeonestyle.com/ JDRF - https://jdrf.org.uk/news-and-events/health-care-professional-events/ Diabetes UK - Type 1 events - https://www.diabetes.org.uk/how_we_help/type-1-events/healthcare-professional-volunteering EXTOD - https://www.extod.org/ The Glucose Never Lies - https://theglucoseneverlies.com/ Diabetes Chat - https://www.diabeteschat.net/   Type 2 -  The 5s - https://www.leicesterdiabetescentre.org.uk/news-blog/ldc-highlights-five-important-health-behaviours-for-diabetes-management Diabetes UK - https://www.diabetes.org.uk/guide-to-diabetes/managing-your-diabetes/exercise , https://www.diabetes.org.uk/node/1155 , https://www.diabetes.org.uk/for-professionals/supporting-your-patients/information-prescriptions/information-prescriptions-qa#download NHS exercise links - https://www.nhs.uk/conditions/nhs-fitness-studio/, https://www.nhs.uk/live-well/exercise/ Other exercise videos -https://www.youtube.com/user/LWRFitnessChannel/videos?app=desktop     General education -  Updating general diabetes knowledge - https://pro.campus.sanofi/uk/type-2-diabetes/education , https://abcd.care/ , https://www.cdep.org.uk/ DSN forum - https://www.diabetesspecialistnurseforumuk.co.uk/hcp-resources Diabetes NNF - https://www.diabetes-nnf.co.uk/  Diabetes Professional Conference - https://www.diabetesprofessionalcare.com/

Warning: This episode is not for the faint of heart or those easily offended. It's raw, it's real, and it's a bit naughty. You've been warned. Brace yourselves for the long-awaited and unabashed Part Two of the Jonsel episode on 'We Are T1D' - the podcast that doesn't just talk diabetes, it lives it. Hosts Mike and Jack, the candid voices of Type 1 Diabetes, delve into the gritty, unpolished side of living with T1D, with their guest who's as real as it gets. Jonsel, a man who's not afraid to speak his truth, shares his journey through the entertainment industry, his battle with the highs and lows of diabetes, and the stark reality of managing this chronic condition in the public eye. From the heartache of empty theatres to the frustration with charities, Jonsel's story is a rollercoaster of emotions and experiences that many with T1D can relate to. Get ready for some outrageous hypo tales that will have you in stitches, discussions on the taboo topic of diabetes and sex, and the kind of uproarious banter that only comes from three guys who know how to laugh in the face of adversity And for those who've been touched by Jon's candidness, his books, 'Diabetes Won't Defeat Us' and 'Keep Calm I'm Only Diabetic', are available on Amazon. Plus, don't miss his powerful short film, 'Hypo', on YouTube - a must-watch that sheds light on the silent struggles of living with T1D. Follow Jonsel on Instagram @jonsel99 and join the conversation that's breaking barriers and building bridges in the T1D community. Remember to Subscribe/Follow, Rate, and Review to support the podcast and help spread the word about the real life of living with Type 1 Diabetes. Share your stories, find your tribe, and never forget - you're not alone on this ride. Until next time, keep it real, keep it raw, and keep laughing through the lows. Peace out, and stay syringed! Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Get your wins on the podcast at https://wearet1d.com  

If you're curious about volunteering, you won't want to miss this episode! Join us as we delve into the exciting world of fundraising. The BullCast team has been actively volunteering for organizations like JDRF and the Memphis Oral School for the Deaf, and we're eager to share what we've learned! Our discussion kicks off with "Fundraising Lessons Learned from Disney," drawing inspiration from Hercules and Moana to explore the rewards of commitment and persistence in fundraising. We'll also share insights from our experiences on different boards, the joys of volunteering, and why now is an ideal time to organize fundraisers. The episode wraps up with practical advice on how you can make a difference by donating your time. Join us for this enlightening and uplifting episode of BullCast and discover how you can "be our guest" in the wonderful world of fundraising! The List: Fundraising Lessons Learned from Disney Hashtags: #fundraising #fundraisingseason #beourguest #gothedistance #CamLovesMoana #DrinkCoffeeEveryTimeWeSayFun Visit us online: www.bullcastpodcast.com Produced by Cameron Spann | Powered by Pickler Wealth Advisors Sound effects obtained from https://www.zapsplat.com

In this episode, Dr. Laura branches away from the specific subject of career fulfillment and speaks with her guest, country music star George Canyon, about spirituality and servanthood. George Canyon has recently released his memoir, My Country, and the book reveals the challenges and adventures he's faced, his determination to help others dealing with Type One diabetes, and the faith that keeps him going.George tells Dr. Laura that though his book is full of vulnerability and authenticity, he shied away from relating negative stories. He chooses positivity wherever he can because, as he says, “nobody needs to read more negativity”. The conversation delves into the challenges his teenage diagnosis of Type One diabetes brought him, how hard he worked to succeed in the music industry, and his spirituality and faith in The Creator that drives him day to day. It's a more spiritual conversation than is usually had with Dr. Laura's guests but it's not tied to any specific religion and it's a conversation full of hope that everyone can benefit from. “... we're humans, we put titles to everything - everybody has to title something, I don't know why. It's just, I guess, to make us feel more safe and conformed. Church, the title church, is a community. It's a community of people. The original churches were held in people's homes. It wasn't a big building you went to with four walls. It was a home where you got together to talk about your faith, to talk about what the Creator's done for you, to encourage each other, to pick each other up, not to be judgmental and condemn each other.” George CanyonAbout George Canyon:George Canyon rose to become one of Canada's hottest Country Music stars in the early 2000s and has won countless accolades and awards, including Juno Awards, CCMA Awards, and ECMA Awards to name a few. He has been inducted into the Nova Scotia Country Music Hall of Fame, recorded 12 albums, and was recently presented a certified Platinum Award for his debut album ‘One Good Friend'. With country hits like Just Like You, I Believe in Angels, Drinkin' Thinkin', Daughters of the Sun, I Got This, I Want You To Live, Slow Dance and many, many more. He is also a highly regarded humanitarian, a strong supporter of the military, and, most importantly, a proud father and devoted husband.Over the years George has also had the privilege of collaborating with fellow talents, a prime example being when he joined forces with multi-platinum pop and rock icon Richard Marx to produce two albums, 2008's ‘What I Do' and 2011's ‘Better Be Home Soon', the latter of which featured When Love Is All You Got, written for George by Marx and the legendary Kenny Rogers. ‘What I Do' was an enormous success, going Certified Gold during the first three weeks of release.George is so much more than an award-winning musical talent. Helping others has always been a huge priority for him, particularly for children with Diabetes and his work as a spokesperson for the Juvenile Diabetes Research Foundation (JDRF).  It's a cause close to Canyon's heart, starting from when he himself was diagnosed with Type-1 Diabetes at the age of 14. In addition to his work with JDRF, George is an ardent supporter of our military, having performed many times for troops overseas and even releasing a moving tribute with the single I Want You to Live, which touches on the very heartbreaking fact that in fighting for our country, some of our troops won't make it back home. The music video for the single features several real soldiers talking about their lives and careers, putting faces to the group of people working to make our country safe.Among his many identities, Canyon is also a proud Canadian and huge hockey fan, and roots for his team, the Calgary Flames, for which he just completed his 8th season singing the national anthem during the home games.Resources:Website: GeorgeCanyon.com“My Country” by George CanyonJuvenile Diabetes Research FoundationGerald Auger on InstagramEpisode 54 | Special Episode on the LiLoHia Project: with guests Gerald Auger and Sass JordanLearn more about Dr. Laura on her website: https://drlaura.liveFor more resources, look into Dr. Laura's organizations: Canada Career CounsellingSynthesis Psychology

In this episode, Lisa and Kristina discuss:Strategies for striking the balance between parental involvement and teen independence.How to listen to and validate your teen's aspirations before giving advice. Why parents need to have honest discussions about their college budget and their financial realities. The importance of highlighting your student's voice and ownership during the application process.Key Takeaways: You do not want to project your experiences, achievements, or failures on your student. They need to live their independent life, not your life vicariously. If you believe your teen is wrong, you can still validate and empathize with them before redirecting them to more constructive thoughts and behavior.It's possible to help your students see the throughlines of their desires by asking why, without telling them your thoughts.There are ways for you to talk to your student about college budget and finances without them knowing every detail of how much you make.While the journey is the student's it's still possible for the parent to play an important, supportive role.  “Support has to be authentic and genuine from the parent, meaning if you're going to support your child in terms of their life, their outcomes, all those things, they have to feel that it's true.” – Kristina DooleyAbout Kristina Dooley: Kristina L. Dooley is a Certified Educational Planner (CEP) and founder of Estrela Consulting, an Ohio-based independent educational consulting firm. Kristina has more than 20 years of experience working with students from around the world, navigating the complex college and school search processes. A first-generation college student, she graduated from Hiram College (B.A.) and Kent State University (M.A.). In addition to her work with students, Kristina is an instructor for the University of California Irvine teaching College Consulting Resources, and also serves as a faculty member of the IECA Summer Training Institute for aspiring educational consultants. Kristina is the Past President of the Independent Educational Consultants Association (IECA), and holds membership in AICEP, NACAC, and the Ohio and International Associations for College Admission Counseling (OACAC & IACAC).  In her free time, Kristina volunteers for Beyond Type 1 and JDRF, and serves as a mentor for College Now Greater Cleveland. She resides in Northeast Ohio with her husband and their 13-year-old triplets. Episode References:Free Video: How to guide your teen to choose the right major, college, & career flourishcoachingco.com/course #048 Building Motivation & Stress Tolerance for Happy Teens with Ned Johnson  #062 Gap Year: Is it a better freshmen start?  #013 The Many Advantages of a Gap Year with Holly Bull Get Lisa's Free on-demand video: How-to guide for your teen to choose the right major, college, & career...(without painting themselves into a corner, missing crucial deadlines, or risking choices you both regret). flourishcoachingco.com/videoConnect with Kristina:Instagram: instagram.com/estrela_consulting Facebook: facebook.com/EstrelaConsulting LinkedIn: linkedin.com/in/kristinadooley Website: estrelaconsulting.com Connect with Lisa:Website: https://www.flourishcoachingco.com/YouTube: https://www.youtube.com/@flourishcoachingcoInstagram: https://www.instagram.com/flourishcoachingco/LinkedIn: https://www.linkedin.com/company/flourish-coaching-co

Suzanne Swiderski is an author, lawyer, wife and mother. She was first introduced to Type 1 Diabetes when she met her husband 13 years ago, who has been living with diabetes for 30 years. Suzanne and her husband have 3 beautiful kids, 2 of which are type 1. Their youngest child, Katie, was diagnosed in 2021 when she was four, and their oldest, Jackson, was diagnosed last year at the age of nine. Despite being a Diabetes family, the Swiderskis have lived a full, adventurous life. They have lived overseas and traveled extensively. Being a former college athlete, Suzanne stresses the importance of physical activity to her family. The Swiderski family has two current athletes with diabetes, which can be daunting and challenging to navigate. Still, despite that, the Swiderski family doesn't let T1D keep them from any activity or adventure they want to experience. When not caring for her children, Suzanne writes historical fiction and volunteers for the PTO, Camp Hope, and JDRF.My Diabetes Resources:Website: www.simplifyingdiabetes.comNewsletter Sign Up"More Than A1C" - My Signature Coaching ProgramThe Diabetes Nutrition Master CourseThe Diabetes Performance JournalDon't forget to check out Ancient Bliss an herbal supplement company.Use Discount Code KEN20 for 20% off at check out.Have a question, send me a DM or email. I'd love to connect and answer any questions you have.You can find the show  on any platform you listen to your podcasts!Don't forget to click on that subscribe button and leave a 5-star review, so you're notified when new episode drop every week.Questions about diabetes, don't hesitate to reach out:Instagram: @CoachK3NInstagram: @thehealthydiabeticpodTwitter: @thehealthydpodTik Tok: @thehealthydiabeticpodFacebook: @Simplifying Life With DiabetesEmail: ken@simplifyingdiabetes.comPodcast Disclaimer: Nothing that you hear on The Healthy Diabetic Podcast should be considered medical advice or otherwise; please always consult your medical TEAM before making any changes to your diabetes management.

Screening for Type 1 diabetes is crucial for earlier detection and management of the disease, but many people don't know that they should be screened or how to access that screening.  In the 2nd episode in our three-part series on T1D screening, University Hospital's Chief of Staff - Office of President & CEO, Franklin Hickey, PhD, RN, NEA, BC, Executive Director of Community and Population Health, Colette Barrow Adams, PhD, MPA, MDiv, and JDRF Patient Navigator, Courtney Harris joined The Huddle to talk about a partnership with JDRF that has allowed more than 1,000 people to be screened for early T1D in the underserved Newark, New Jersey area. They also discuss the importance of meeting people where they are and understanding barriers to access when looking to increase screening rates. Educational grant support for this episode is provided by Sanofi.Learn more about University Hospital here: Hospital Administration - University Hospital (uhnj.org)Lean more about JDRF here: JDRF - Diabetes - Type 1 Diabetes Research, Advocacy, and SupportLearn more about the partnership between University Hospitals and JDRF here: Inclusive Health: Creating Access to Type 1 Diabetes Screening in Underserved Communities (beyondtype1.org) Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Are you a solo recruiter curious about achieving extraordinary billing figures with just a handful of daily conversations? Meet Craig, a solo recruiter who's been smashing records. For the last 3 consecutive years, he's billed over $1.25m as a solo recruiter, reaching a career milestone of $1.5m in 2023, which was a down year for many recruiters. In today's episode, we explore how solo recruiters can level up their recruitment game with conversations even when times are tough with a returning guest, Craig Picken. Craig is the co-founder and Managing Partner for Northstar Group, a boutique executive search firm based in Wilmington, NC.     Tune in and get invaluable insights from Craig's unique approach that challenges the norms and redefines what's possible for solo recruiters in today's competitive landscape. His ability to navigate the complexities of talent acquisition is truly remarkable. Whether you're a seasoned recruiter or just starting out in the industry, this episode offers actionable tips to enhance your recruitment conversations and propel your career to new heights.    Episode Outline And Highlights [03:47] The conversations that contributed to Mike's 1.5m billing record  [06:37] What qualifies the right conversations and people [10:03] Two tools for tracking recruitment conversation  [14:42] How to ring the phone and create “spontaneous conversations.” [20:11] How to position yourself for the long game and value “not transactions.” [27:53] Non-negotiables for success when partnering with a client  [34:50] How to avoid burnout: Solo recruiters' physical and mental self-care tips  [42:14] What solo recruiters can do to level up to $3-400k recruiters [48:35] Craig's philosophy of content creation and tactics for writing [54:54] How podcasting can drive conversations and position you as an expert [57:26] Strategies to building a 10K people email list for your podcast [58:44] How to do outbound calls and the volume of calls to puts out there [01:01:08] What solo recruiters need to do today to be successful tomorrow 5 Steps to Level Up Your Recruitment Business Craig and I discussed his recruitment strategies at Northstar Group company, a boutique executive search firm based in Wilmington, NC, that focuses on recruiting senior-level leadership, sales, and operations executives for some of the most prominent companies in the aviation and aerospace industry. Craig's clients include well-known aircraft OEMs, aircraft operators, leasing / financial organizations, and Maintenance / Repair / Overhaul (MRO) providers. With a track record spanning over a decade, Craig has personally concluded hundreds of successful executive-level searches across a variety of disciplines. Craig outlined five essential steps for recruiters looking to elevate their game:   Invest in Yourself: Craig emphasized the importance of self-investment, urging recruiters to spend some money, go to conferences, engage in level-up conversations, and continuously seek opportunities for personal and professional growth. Follow the Right People: Recognizing the challenges of talent acquisition, Craig advised recruiters to connect with industry leaders to enhance their credibility and reputation as go-to experts. Following the right people will help you become a destination of choice.  Know who you are working with: Success in recruitment, according to Craig, hinges on understanding your clients, delivering value, nurturing relationships, and adopting a long-term perspective. Choose Your Battles Wisely: Drawing from his experience and insights from the Naval Top Gun program, Craig shares a valuable lesson: “If you can't win the fight, don't fight. Go away and come back. Live to fight another day,” which is a great philosophy in recruiting. Differentiate yourself: Craig encouraged solo recruiters to carve out their unique identity and differentiate themselves from the competition. Whether through thought leadership on platforms like LinkedIn or showcasing their authentic self, it can significantly impact their success in the field.   Ultimately, leveling up in recruitment involves positioning yourself as a trusted industry expert, promoting your voice, and leading by example.  Positioning Yourself In The Market Craig shares the importance of positioning oneself in the market not merely as a transactional recruiter but as an invaluable resource, an expert dedicated to adding tangible value. By prioritizing value over closing deals, recruiters can elevate their status in the client's eyes. Rather than seeking short-term gains, they should aim to build lasting relationships grounded in trust and mutual benefit. According to Craig, the last thing he wants to be in his life is transactional, which is here today and gone tomorrow. Positioning yourself in the market is about relationships and being with your clients every step of the way. It's about maintaining a client-centric approach throughout the entire engagement process, being present, reliable, and supportive at every stage, regardless of the challenges or obstacles. This commitment to the long game ensures that clients and prospective clients feel supported and understood, strengthening the bond and attracting more business. In addition, Craig advocates for prioritizing integrity over immediate financial gain. When recruiters focus on delivering exceptional results, monetary rewards will naturally follow. Don't succumb to desperation or compromise on your principles for money; this can lead to dissatisfaction and ultimately damage the client relationship. Be willing to walk away from situations that don't align with your values to ensure you can pursue mutually beneficial partnerships built on trust and respect.   Our Sponsor   This podcast is proudly sponsored by i-intro    i-intro® is an end-to-end retained recruitment platform. Their technology and methodology allow recruiters to differentiate themselves from the competition, win more retained business, bigger fees, and increase their billings. Their software combined with world-class training enables you to transition from transactional, contingency recruiter to consultative, retained recruiter. Instead of being perceived as a “me too” vendor, you'll be positioned as a “me only” solutions provider. Be sure to mention Mark Whitby or The Resilient Recruiter. Book your free, no-obligation consultation here: https://recruitmentcoach.com/retained   Craig Picken Bio and Contact Info   Craig is the Co-founder and Managing Partner for Northstar Group, a boutique executive search firm based in Wilmington, NC. Craig is focused on recruiting senior-level leadership, sales, and operations executives for some of the most prominent companies in the aviation and aerospace industry. Clients include well-known aircraft OEM's, aircraft operators, leasing / financial organizations, and Maintenance / Repair / Overhaul (MRO) providers. Since 2009 he has personally concluded several hundred executive-level searches in a variety of disciplines.   Craig on LinkedIn Craig on Twitter @craigpicken Craig on Facebook  Northstar Group website JDRF website   Resources and People Mentioned LinkedIn Sales Navigator Clockwork Recruiting   Related Podcast You Might Enjoy   TRR #22 Craig Picken's Journey From Naval Aviator to Big Billing Solo Recruiter   Connect with Mark Whitby Get your FREE 30-minute strategy call Mark on LinkedIn Mark on Twitter: @MarkWhitby Mark on Facebook Mark on Instagram: @RecruitmentCoach   Subscribe to The Resilient Recruiter   If you've been enjoying the podcast, please take two minutes to leave a review. Your review is greatly appreciated because it helps us attract a bigger audience and help more recruiters.

Advanced practice dietitian Amy Hess Fischl MS, RD, LDN, BC-ADM, CDE joined The Huddle to talk about the various food factors that can impact glucose levels, how to help people with diabetes address and understand the factors that impact them most, and how people with diabetes may adjust their insulin doses based on these various factors.This podcast is being produced in collaboration with JDRF. JDRF works to improve the lives of individuals living with T1D by providing meaningful educational resources for health care professionals and community members. See a full list of factors that can impact glucose levels on Diatribe here: 42 Factors That Affect Blood Glucose?! A Surprising Update (diatribe.org)Learn more about JDRF here: JDRF - Diabetes - Type 1 Diabetes Research, Advocacy, and Support  Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast. Learn more about ADCES and the many benefits of membership at adces.org/about-us/membership.

Cliff Avril, with a 10-year NFL career as a Defensive End starting in 2008 with the Detroit Lions and later joining the Seattle Seahawks, achieved back-to-back Super Bowl trips in 2013 and 2014. Notable for recording the fastest NFL score in 2013, he received a Pro Bowl nod in 2016. Beyond football, Cliff is a committed philanthropist, named the 2016 Seahawks Walter Payton Man of the Year. He co-founded the Cliff Avril Family Foundation in 2014, engaging in various community initiatives, from free football camps to supporting health causes. His foundation's impact extends globally, building schools and homes in Haiti. As a Board member at JDRF and St. Thomas, and with his involvement in real estate through CA Family Properties and joint ventures, Cliff Avril continues to leave a lasting legacy both on and off the field.   Here's some of the topics we covered:   Cliff's NFL Background  Where To Look For Multifamily Deals The Similarity In Teamwork Between The NFL & Multifamily Not Learning Until You Take Action Giving Back To The People You Love Most Keeping Your Children Grounded In Reality Putting a Multifamily Game Plan Together Mentoring Younger People For Success The Fear Of Breaking Out Of The Comfort Zone Cliff's Foundation and Charity Work To find out more about partnering or investing in a multifamily deal: Text Partner to 72345 or email Partner@RodKhleif.com    Please Review and Subscribe

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new study looks at food-as-medicine for type 2, another FDA warning about fake Ozempic, new research says gut markers may help predict who Tzield will work best for, JDRF partners with NFL and more... Happy New Year - we'll see you in 2024! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX Our top story this week… XX You often hear people say food is medicine.. but an intensive program trying to show that's the case did NOT improve glycemic control in adults with type 2 diabetes any better than usual care. This was a randomized clinical trial. After 6 months, both groups had a similar drop in HbA1c -- 1.5 percentage points among program enrollees and 1.3 percentage points with usual care, with no significant differences in other metabolic lab values between the groups either, the researchers wrote in JAMA the food-as-medicine participants even gained some weight compared with the usual care group over 6 months (adjusted mean difference 1.95 kg, P=0.04). "I was surprised by the findings because the program is so intensive," Doyle told MedPage Today. "The health system built brick-and-mortar clinics, staffed them with a dietitian, nurse, and community health worker, had weekly food pick-up for 10 meals per week for the entire family, and participants spend a year in the program."   Costing an estimated $2,000 annually per participant, the food-as-medicine program allowed participants to choose from a variety of vegetables, fruits, and entrees each week -- enough food for two meals a day, 5 days a week. They were also provided recipes and cooking instructions and met with dietitians to track goals. On the other hand, the control group was only provided usual care, a list of local food bank locations, and the option to join the program after 6 months.     The trial was conducted at two sites, one rural and one urban, in the mid-Atlantic region. It recruited 465 adults with type 2 diabetes who completed the study, all of whom started with an HbA1c of 8% or higher. All participants were also self-reported as food insecure. The average age was 54.6 years, 54.8% of participants were female, 81.3% were white, and most resided in the urban location. Of note, all participants also resided in the program's service area and were affiliated with the health system that ran it.   "One study should not be over-interpreted," said Doyle. "It is possible that such a program could work in other contexts, among patients less connected to a health system, or in other formats. The main alternative to providing healthy groceries and education is to provide pre-made 'medically tailored meals.'"   "I hope the study raises awareness of the potential for food-as-medicine programs to increase healthcare engagement and to push researchers and policymakers to generate more evidence on ways such programs can improve health." It's worth noting that there is very little study – much less clinical trial level study on this type of thing. The researchers say they hope it spurs more research to find methods that will have a large impact. https://news.mit.edu/2023/food-medicine-diabetes-study-1227 https://www.medpagetoday.com/primarycare/dietnutrition/107998   XX New information about moderate low carb diets for people with type 1. The study published in The Lancet Regional Health - Europe is the largest of its kind to date. Participants were for different periods randomly assigned in a crossover manner to eat a traditional diet with 50% of the energy from carbohydrates, or a moderate low-carbohydrate diet with 30% of the energy from carbohydrates.   The 50 participants all had type 1 diabetes with elevated mean glucose, long-term blood sugar, and injection therapy with insulin or an insulin pump. Half were women, half men. The average age was 48 years. Participants on a moderate low-carbohydrate diet were found to spend more time in what is known as the target range, the range within which people with type 1 diabetes should be in terms of glucose levels. The increase in time within the target range was an average of 68 minutes per day compared to the traditional diet, while the time with elevated values ​​was reduced by 85 minutes per day. The researchers saw no evidence of adverse effects. https://www.news-medical.net/news/20231220/Moderate-low-carb-diet-safe-and-effective-for-adults-with-type-1-diabetes.aspx   XX Researchers at Case Western Reserve University and University Hospitals have identified an enzyme that blocks insulin produced in the body—a discovery that could provide a new target to treat diabetes.   Their study, published Dec. 5 in the journal Cell, focuses on nitric oxide, a compound that dilates blood vessels, improves memory, fights infection and stimulates the release of hormones, among other functions. How nitric oxide performs these activities had long been a mystery.   The researchers discovered a novel “carrier” enzyme (called SNO-CoA-assisted nitrosylase, or SCAN) that attaches nitric oxide to proteins, including the receptor for insulin action. Given the discovery, next steps could be to develop medications against the enzyme, he said. https://thedaily.case.edu/new-cause-of-diabetes-discovered-offering-potential-target-for-new-classes-of-drugs-to-treat-the-disease/ XX The Food and Drug Administration on Thursday warned consumers not to use counterfeit versions of Novo Nordisk's diabetes drug Ozempic that have been found in the country's drug supply chain.   The FDA said it will continue to investigate counterfeit Ozempic 1 milligram injections and has seized thousands of units, but flagged that some may still be available for purchase. The agency said the needles from the seized injections are counterfeit and their sterility cannot be confirmed, which presents an additional risk of infection for patients.   Other confirmed counterfeit components from the seized products include the pen label and accompanying information about the healthcare professional and patient, as well as the carton. The FDA urged drug distributors, retail pharmacies, healthcare practitioners and patients to check the drug they have received and to not distribute, use or sell the units labeled with lot number NAR0074 and serial number 430834149057.   People who have Ozempic injections with the above lot number and serial number can report it directly to the FDA Office of Criminal Investigations. https://www.nbcnews.com/health/health-news/fda-warns-ozempic-counterfeit-diabetes-weight-loss-rcna130871 XX New research indicates that information in the gut may predict how well a person responds to Tzield. That's the medication approved earlier this year to delay the onset of type 1.  These findings reported in the journal Science Translational Medicine, casts a new spotlight on the immune system's relationship with the microbiome, revealing how gut microbes can shape the progression of type 1 diabetes. With this new knowledge in hand, clinicians may better pinpoint patients who are most likely to respond to teplizumab. https://medicalxpress.com/news/2023-12-gut-microbes-patients-response-drug.html   XX Experts are advocating for universal screening for type 1 diabetes. With the availability of Tzield and other medications on the horizon, there's a stronger push for screening earlier in life. At least 85% of people who are newly diagnosed do not have a family history of diabetes. Testing for autoantibodies can be completed at home through the TrialNet clinical trial program, or at a doctor's office or lab. For instance, JDRF's T1Detect program provides at-home testing for $55, with lower-cost options for people in financial need. The 2024 American Diabetes Association (ADA) Standards of Care recommend more intensive monitoring for the progression of preclinical type 1 diabetes. The Standards of Care also recommend using Tzield to delay the onset of diabetes in people at least 8 years old with stage 2 type 1 diabetes. https://diatribe.org/type-1-diabetes-it%E2%80%99s-time-population-wide-screening XX Commercial XX   https://www.healthline.com/health-news/the-years-biggest-medical-advancements-in-diabetes-treatment XX DRF, the leading global funder of type 1 diabetes (T1D) research, is recognizing the NFL stars who showcased their creativity and a remarkable show of support as part of the highly anticipated annual "My Cause My Cleats" (MCMC) campaign.   The My Cause My Cleats initiative allows NFL players to wear custom-painted cleats during selected games to raise awareness and funds for the charitable causes closest to their hearts. The unofficial start of the campaign begins on Giving Tuesday with unboxing day events showcasing the players' cleats and the stories behind them. It continues through weeks 13 and 14 of the season, culminating with the players donning their cleats on game day. After the games, some players donate their cleats to their chosen charities or the NFL auction, with all proceeds going toward their selected causes.   Type 1 Diabetes is a life-threatening autoimmune condition that affects people of all ages, regardless of family history or lifestyle choices. To live, people with T1D must carefully balance injecting or infusing insulin with their carbohydrate intake throughout the day and night. T1D impacts approximately 1.6 million people in the U.S. It is unpreventable, and there is currently no cure.   This year, JDRF is thankful for the support of several players who have T1D or are advocating for their loved ones with T1D, including Mark Andrews of the Baltimore Ravens, Orlando Brown, Jr. of the Cincinnati Bengals, Blake Ferguson of the Miami Dolphins, Collin Johnson of the Chicago Bears, Chad Muma of the Jacksonville Jaguars, Nate Peterman of the Chicago Bears, and Kevin Radar of the Tennessee Titans.   "The NFL players who support JDRF through the My Cause My Cleats exemplify the passion and determination at the heart of the type 1 diabetes community," said Kenya Felton, JDRF Director of PR and Celebrity Engagement. "They serve as inspirations for many adults and children affected by T1D, demonstrating that with an understanding of T1D, effective management, and a good support system, you can overcome the challenges of the disease. Their support helps to increase awareness and is significant in helping JDRF advance life-changing breakthroughs in T1D research and advocacy initiatives."   Since its inception in 2016, the MCMC campaign has provided a platform for many NFL players and affiliates to support JDRF's mission, including Beau Benzschawel, David Carr, Will Clarke, Keion Crossen, DeAndre Carter, Reid Ferguson, Jaedan Graham, Jarvis Jenkins, Collin Johnson, Henry Mondeaux, Jaelan Phillips, Adam Schefter, Brandon Wilds, and Jonah Williams. https://www.prnewswire.com/news-releases/nfl-stars-support-jdrf-and-champion-type-1-diabetes-awareness-through-the-my-cause-my-cleats-campaign-302022060.html   XX Join us again soon!    

Understanding the ins and outs of Type 1 diabetes and its stages is key in accurately screening for and managing the disease. In the first of a three-part series, we're joined by Associate Vice President of T1D Education and Clinical Implementation at JDRF and 2023 Diabetes Educator of the Year Anastasia Albanese-O'Neill, PhD, APRN, CDCES. In this episode, Dr. O'Neill talks about common misconceptions of T1D, as well as the stages of T1D and the importance of evaluating and understanding these stages when diagnosing and working with people and families affected by T1D.  Educational grant support for this episode is provided by Sanofi. Learn more about T1D risk screening and additional resources on JDRF's website: https://www.jdrf.org/t1d-resources/t1detect/ Learn more and gain access to T1D screening kits via TrialNet: https://www.trialnet.org/ or ASK: https://www.askhealth.org/?_ga=2.144097589.1682361371.1702935724-1205645336.1702935724 Learn more about the Search for Diabetes in Youth study here: SEARCH FOR DIABETES IN YOUTH Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle/podcast. Learn more about ADCES and the many benefits of membership at adces.org.

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: an existing drug for arthritis is being studied for treatment of T1D, poison control centers report a big increase in calls about misdosing of Ozmepic and semaglutides, Tandem releases it's Tandem Source software, we've got an update on a possible non invasive glucose monitoring system, ADA releases it's standards of care and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX Our top story this week… XX A world-first clinical trial has found a common drug used to treat rheumatoid arthritis can suppress the progression of type 1 diabetes in recently diagnosed patients. Australian reserachers say they've discovered that baricitinib *bare-uh-sit-en-ub* can preserve the body's own insulin production. The scientists recruited 91 people, aged between 10 and 30 years old, to take part in the double-blind randomised trial. All patients had been diagnosed with type 1 diabetes within the last 100 days and continued with their prescribed insulin therapy throughout the study. The results showed those in the baricitinib group were able safely and effectively to preserve their body's own insulin production and suppress the progression of type 1 diabetes. "Our trial showed that, if started early enough after diagnosis, and while the participants remained on the medication, their production of insulin was maintained. "People with type 1 diabetes in the trial who were given the drug required significantly less insulin for treatment." Dr Faye Riley, research communications manager at Diabetes UK, said of the latest trial: "These findings show by tackling the root of type 1 diabetes - an immune system attack - an existing drug can help to shield the pancreas, in people recently diagnosed with type 1, so they can continue making more insulin for longer. "This can give people with type 1 diabetes much steadier blood sugar levels and help to protect against serious diabetes complications down the line. "Immunotherapies are edging us towards a new era in type 1 diabetes treatment, and could help us overcome a major hurdle en route to finding a cure for the condition. "This trial takes us another step closer." The study was funded by JDRF, a non-profit organization which focuses on type 1 diabetes research. The research has been published in the New England Journal of Medicine. https://news.sky.com/story/world-first-trial-finds-arthritis-drug-may-help-treat-type-1-diabetes-13024706 XX Earlier this month, Dexcom's G7 became compatible with two pump systems: Beta Bionic's ilet pump and Tandem Diabetes tslim X2. Current customers should have received instructions on how to download the updated software – new pumps will be shipped with G7 software already loaded. Tandem has also announced their new Tandem Source platform – full launch in the US with international rollout slated for next year. Anyone in the U.S. who uses a Tandem pump—as well as their respective healthcare providers—will now have access to the Source platform. On the patient side, insulin dosage data will automatically transfer from the pump to the platform, by way of the t:connect mobile app, where it'll be compiled into three reports for your doctor. Patients will also be able to use the platform to access new software updates for their pumps and to reorder supplies as needed. Long term, the company hopes to use the data from users – which would be blinded- to update automated insulin dosing algorithms. https://www.fiercebiotech.com/medtech/tandem-begins-full-us-rollout-source-diabetes-management-platform XX New look at benefits from a plant based diet – this research says it can reduce the risk of type 2 diabetes by 24%. It's not just about weight loss. They reviewed data on more than 113,000 participants in a large-scale British observational study, gathered over 12 years. They found that normal values for cholesterol, blood sugar, inflammation, and insulin are associated with a low risk of diabetes. They also found that good liver and kidney function is important in diabetes prevention. A plant based diet helped with all of those factors. The researchers do point out that there is such a thing as an unhealthy plant-based diet. Those that are still high in sweets, refined grains and sugary drinks are associated with an increased risk of type 2 diabetes, researchers found. https://www.usnews.com/news/health-news/articles/2023-12-13/plant-based-diets-cut-diabetes-risk-by-24 XX Reports of more patients with type 2 diabetes having trouble getting coverage for medication like Ozempic and Mounjaro – because health insurance companies are putting new restrictions in place. Most U.S. health plans cover GLP-1s for type 2 diabetes but many providers will prescribe it off label for weight loss. There is another medication – Wegovy – approved for weight loss, it's the same drug as Ozempic just packaged in a difference dose and name. The average number of weekly Ozempic prescriptions rose 33% between the first and third quarters of this year, but has since dropped more than 6% to about 431,000, according to Iqvia Institute for Data Science. Doctors and patients are bracing for changes in January, when individual health plans often set new coverage terms. "It may be that January 1, all of a sudden something that was covered is no longer," said Dr. Robert Gabbay, chief science officer at the American Diabetes Association. https://www.reuters.com/business/healthcare-pharmaceuticals/us-diabetes-patients-face-delays-insurers-tighten-ozempic-coverage-2023-12-12/ XX Poison control centers across the US say they are seeing a steep increase in calls related to semaglutide, with some people reporting symptoms related to accidental overdoses. From January through November, the America's Poison Centers reports nearly 3,000 calls involving semaglutide, an increase of more than 15-fold since 2019. In 94% of calls, this medication was the only substance reported. The compounded versions of semaglutide are often different from the patented drug. Many contain semaglutide salts called semaglutide sodium and semaglutide acetate. The FDA says the salt forms of the drug have not been tested and approved to be safe and effective the way the patented form of the medication has, and thus they don't qualify for the compounding exemption in the law for drugs in shortage. In other cases, the compounded versions are sold in unapproved dosages. But these compounded versions are popular because they may cost less out-of-pocket, especially if the treatment isn't covered by insurance. The name-brand drugs are sold in pre-filled pens, which come with some safeguards. Patients dial to the correct dose and click to inject, so it's harder to make mistakes. Compounded versions, however, typically come in multidose glass vials, and patients draw their own doses into syringes. It's easy to get confused. https://www.cnn.com/2023/12/13/health/semaglutide-overdoses-wellness/index.html XX XX Type 2 diabetes patients who received endocrinology care through telehealth alone had poor glycemic outcomes compared with those who received in-person or hybrid care, which contrasts with prior research findings, according to a new study. Previous research has shown that telehealth is effective in improving glycemic control, but there has not been enough data on utilization and outcomes linked to routine telehealth care for type 2 diabetes since 2020, especially in the endocrinology setting, the researchers wrote. One reason may be that the strategies to support glycemic improvement deployed during in-person appointments, like self-management education and sharing home blood glucose data, have not been consistently translated to telehealth. “Implementation of approaches to overcome these differences, such as team-based virtual care and technological tools to automate blood glucose data sharing, are needed to ensure all patients receive high-quality diabetes care regardless of care modality,” they wrote. These study findings contrast with previous research, including a study published in early 2022 that revealed that telehealth maintained quality of care and led to better health outcomes for patients with type 2 diabetes during the COVID-19 pandemic. The study included 16,588 with type 2 diabetes who received care before or during the pandemic, with 7,581 having a telehealth visit with either a primary care physician or an endocrinologist. https://mhealthintelligence.com/news/telehealth-only-care-fails-to-improve-type-2-diabetes-outcomes XX Medtronic's deal to buy a South Korea based insulin patch pump maker is off. Back in May Medtrnoic announced a 738-million dollar deal to buy EOFlow, which makes EOPatch, a tubeless, wearable and fully disposable insulin delivery device. EOFlow already launched its EOPatch insulin delivery system in Korea and Europe. The company submitted the insulin delivery device for U.S. FDA clearance in January. https://www.massdevice.com/medtronic-nixes-738m-deal-for-insulin-patch-pump-maker-eoflow/ XX Commercial XX Update on non invasive continuous glucose monitoring. The most recent validation of the technology's accuracy has been released as a preprint. In an experiment, researchers fed thousands of radio frequency glucose readings into a machine learning model to translate them into blood sugar values and compared the results against those from a Dexcom G6. CGM accuracy is judged by mean absolute relative difference, or MARD. The statistic is reported as a percentage: a MARD of 10 percent, for example, means that the CGM is on average within 10 percent of the reference value. The Bio-RFID system scored a MARD of 11.27 percent. In truth, this result is difficult to interpret. Though Bio-RFID's MARD is not yet in the same neighborhood as its competitors' (the Freestyle Libre 3 and the Dexcom G7 report MARDs of 7.9 percent and 8.7 percent, respectively), the experiment wasn't a true test of the device's capabilities, because it didn't use a lab-drawn glucose measurement as its reference value. The volunteers also did not have diabetes, which meant that their blood sugar levels were likely more stable than those of most future customers. The FDA has specific accuracy standards that it expects CGM manufacturers to meet for devices intended for “nonadjunctive” use and for use in a closed-loop insulin pump system. Know Labs's product will need to meet these objective standards to be validated as a truly reliable CGM. The Path to Approval “Our expectation is that we'll be in front of the FDA as we move into the second half of 2024,” says Erickson. Much larger trials will be needed to show that the device works and meets FDA standards. Erickson says, “We expect to have an FDA-cleared device in 2025.” Though the business is still finalizing the form of the next generation, it expects that it can navigate the FDA approval process quickly. The FDA has already confirmed that RFID is quite safe and there should be little worry about side effects (though there could be a hazard of interference for patients already using electronic medical devices such as pacemakers). https://www.diabetesdaily.com/blog/this-company-is-racing-to-create-the-worlds-first-non-invasive-cgm-718069/ XX Today, the American Diabetes Association® (ADA) released the Standards of Care in Diabetes—2024 (Standards of Care), a set of comprehensive and evidence-based guidelines for managing type 1, type 2, gestational diabetes, and prediabetes based on the latest scientific research and clinical trials. It includes strategies for diagnosing and treating diabetes in both youth and adults, methods to prevent or delay type 2 diabetes and its associated comorbidities like cardiovascular disease (CVD) and obesity, and therapeutic approaches aimed at minimizing complications and enhancing health outcomes. "The latest ADA guidelines present pivotal updates for health care professionals, ensuring comprehensive, evidence-based care for diabetes management. These changes reflect our ongoing commitment to optimizing patient outcomes through informed, adaptable, and patient-centered health care practices,” said Robert Gabbay, MD, PhD, the ADA's chief scientific and medical officer. “The ADA's Standards of Care ensures health care professionals, especially our primary care workforce, provide the best possible care to those living with diabetes.” Notable updates to the Standards of Care in Diabetes─2024 include: New updates in managing obesity in people with diabetes, including approaches to reduce therapeutic inertia, support more personalization, and incorporate additional obesity measurements beyond body mass index (i.e., waist circumference, waist-to-hip ratio, and/or waist-to-height ratio). New screening recommendations for heart failure in people with diabetes. Updated recommendations for peripheral arterial disease (PAD) screening in people with diabetes. Guidance on screening and the use of teplizumab, approved to delay the onset of type 1 diabetes. More guidance on the use of new obesity medications, glucagon-like peptide 1 (GLP-1) agonists or dual glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, to reach sustained weight management goals. Updates in guidance on the diagnosis and classification of diabetes. A focus on hypoglycemia prevention and management. Emphasis on screening people with diabetes for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis at primary care and diabetes clinics. New emphasis on the evaluation and treatment of bone health and added attention to diabetes-specific risk factors for fracture. A focus on screening and management of people with diabetes and disability. Emphasis on enabling health care providers to master diabetes technology, using artificial intelligence for retinal screenings with necessary referrals, and embracing telehealth and digital tools for diabetes self-management education. New information on the possible association between COVID-19 infections and new onset of type 1 diabetes. "As the ADA's chair of professional practice committee, I'm excited to share our latest updates to advance diabetes care through new scientific insights and technological innovation, all aimed at enhancing experience for people with diabetes and health care professionals in managing this complex condition," said Nuha A. El Sayed, MD, MM Sc, the ADA's senior vice president of health care improvement. Other noteworthy changes to the 2024 Standards of Care include: Updated immunization guidance to include newly approved RSV vaccines in adults over 60 years of age with diabetes. New emphasis on cultural sensitivity in diabetes self-management education, with considerations for changing reimbursement policies. More detail and emphasis on psychosocial screening protocols to better identify diabetes distress. The importance of diabetes technology, with an emphasis on continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems. Continued emphasis on inclusion and person-centered care. “At the ADA, we are focused on improving the quality of care for anyone who lives with diabetes, prediabetes, or who is at risk of developing diabetes. The Standards of Care is critical to ensuring the improved treatment of diabetes, a chronic disease that requires continuous care through a well-informed and coordinated health care team. These standards equip health care professionals with the gold standard in diabetes care, ensuring the highest level of service and knowledge in the field,” said Chuck Henderson, the ADA's chief executive officer. The ADA annually updates its Standards of Care through the efforts of its Professional Practice Committee (PPC). Comprising 21 global experts from diverse professional backgrounds, the PPC includes physicians, nurse practitioners, certified diabetes care and education specialists, registered dietitians, pharmacists, and methodologists. Its members hold expertise in areas like adult and pediatric endocrinology, epidemiology, public health, cardiovascular risk management, kidney disease, microvascular complications, preconception and pregnancy care, weight management, diabetes prevention, behavioral and mental health, inpatient care, and technology in diabetes management. Additionally, the committee collaborates with 19 specialized content experts. The 2024 Standards of Care has garnered endorsements from the American College of Cardiology (Section 10), the American Society of Bone and Mineral Research (Bone section in Section 4), and the Obesity Society (Section 8). Today, the Standards of Care in Diabetes—2024 is available online and is published as a supplement to the January 2024 issue of Diabetes Care®. A shortened version of the guidelines, known as the Abridged Standards of Care, will be made available for primary care providers in the journal Clinical Diabetes®, along with a convenient Standards of Care app as well as a Standards of Care pocket chart. The online version will be annotated in real-time with necessary updates if new evidence or regulatory changes merit immediate incorporation through the “living” Standards of Care process. Other Standards of Care resources, including a webcast with continuing education (CE) credit and a full slide deck, can be found on the ADA's professional website, DiabetesPro®. https://diabetes.org/newsroom/press-releases/american-diabetes-association-releases-standards-care-diabetes-2024 XX Join us again soon!  

This episode title is a bit misleading (sorry!) because Benny is actually marking 17 years with type 1! He's away at college and while I hope to talk to him for the show soon, we just couldn't swing it in time for his actual diaversary. To mark the date, we're going to replay the first time I talked to Benny for this podcast – which I did along with my husband and my daughter back in 2016. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Find out more about Moms' Night Out - we have announced FOUR LOCATIONS for 2024! Use promo code MOM30 to save $30 off any city This is a longer episode, so I wanted to break it down a bit - and a full transcription is below. 00:00 2023 Stacey introduction, talks about Benny's 17th diaversary 03:55 2016 Stacey explains how the order of interviews and a few housekeeping notes 05:22 Slade 24:27 Lea 40:42 Slade (part 2) 1:12:15 Benny 1:26:07 2023 Stacey wraps it up   Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription below - our transcription service doesn't speak diabetes perfectly, so please excuse any mistakes. Thanks! Stacey Simms 0:05 This is Diabetes Connections with Stacey Simms. This week is my son's 17th diversity 17 years with type one to mark what's really his entry into being a young adult with T1D. He's almost 19 We're going to take a look back at when he was a lot younger. We've got a replay of the first time I talked to Benny for this podcast back in 2016. It's a conversation that also includes my husband and my daughter. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Welcome to another week of the show. I'm your host, Stacey Simms. And you know, we aim to educate inspire about diabetes with a focus on people who use insulin. I am not great about remembering Benny's exact dye aversary. And most of the reason why is because his diagnosis was very, it was prolonged, I would say it really only took a week, maybe a week or a couple of days from the time that I called our pediatrician and said, I don't like what I'm seeing Something's really wrong to an actual in hospital diagnosis and, and all the education that goes with it. But we had so many bumps along the way. And I've told these stories before, you know, a fasting blood glucose. That was normal, it was 80. And that was on a Monday. And then some subsequent diagnoses of things that we now know were just symptoms, you know, infection, things like that, that they treated, and we thought, yeah, we got it. And then finally, the A1C results, which came back five days after that initial fasting blood glucose, which is when they sent us to the hospital, all of that to say I remember the days of the week, Monday was the pediatrician Saturday was the phone call to go to the hospital. But I never remember the actual dates. Social media memories usually remind me and sure thing they came up this morning. So I'm recording this on Benny's actual 17 year diver serie on December 2, December also means and I need to tell you one quick thing about moms night out that the early bird special for Charlotte is over. I do have a promo code for you that you can use on the regular price to save $30 off. And that promo code is m n o 30. Mom's night out m and o 30. You'll save $30. With that I will put a link in the show notes. You can always go to diabetes dash connections.com. We have a mom's Night Out tab as well there now. If you go there we are announcing our next cities this week, I may have already done so. So follow on social for that announcement or click on over to the website, click on the mom's side out tab. See the new cities registration is not open for them. But you can sign up to be emailed directly when registration does open. And for more information. All right. I am hoping to talk to Benny for a new episode soon. As you know he's away at college. And I cannot wait to get that kid home for winter break. As this episode goes live. I think he's coming home in about 10 days, not that I'm counting diabetes, while he's been away has been fine. But I've tried really hard not to ask him a lot of bout it other than once in a while like you're doing okay. Right? Because we don't follow his Dexcom anymore. And I really don't know much day to day. You know, he's reordered supplies with me. So I know he's he's doing that kind of stuff. I can't wait to talk to him more. I will let you know when we're going to be taking questions for that episode, we'll post to the Facebook group for that. These conversations you're about to hear were recorded in fall of 2016. Benny is in sixth grade, his voice hasn't even changed yet. Oh, my goodness, I left in the original introduction, which gives more context. But I also want you to know, this is a much longer discussion than I remember. So I'm going to do more comprehensive shownotes with some time codes, if you want to kind of jump around on this episode and pick and choose where you want to listen. So here we go. My family's thoughts on one decade. Remember, this is seven years ago with type one. Stacey Simms 03:55 This part of the podcast is usually where I interview somebody else get them to share their story and their thoughts about living with diabetes. This is different. This is my family's story. And let me tell you, this is what I've done my entire career, talk to people interview people since before I even graduated from college. And these are the toughest interviews I've ever done. I was so nervous. But they were they were wonderful. And I was just thrilled that they agreed to even talk to me. My husband and my daughter are really not front and center. Attention people. I don't know how they live that way. But here's how it's going to go. You're going to first hear from me and my husband Slade. And then you'll hear from Leah. We're in the middle of that interview. I'm going to pause the conversation. And then you'll hear Leah's interview, because I had maybe the most Frank, honest and open conversation about our brothers diabetes that we've ever had. And then we'll wrap that up and you'll hear more from me and slay And then finally you'll hear from Benny. Oh my gosh, that kid, if you have a middle school boy, maybe you'll understand that conversation was, let's say it was interesting. There is a bit of overlap in these conversations as you'd expect. I mean, there are some events that we all talk about. So you'll hear about those things more than once, that sort of thing. Okay, here we go. I'm really interested to see what we talked about today because Slade doesn't really talk about Benny's diabetes publicly. I mean, of course, you you're very, very involved, and you talk about it, I'm sure with friends, and things like that. But it's not like you are front and center at functions. And, you know, that kind of thing over the years, I don't Slade 5:41 have a podcast, Stacey Simms 5:43 I could help you set one up. But I've been told in the past, I speak enough for everybody in the family. So I'm really interested to hear what you have to say if your conversation matches mine. Alright, so let's start 10 years ago, Ben, he was diagnosed with type one. He was not yet two years old. And Leo was just had just turned five. What I remember vividly is the month before he was diagnosed, when I was working at WB T, doing morning radio, you got the kids every morning. So you used to text me, like 730 or seven o'clock every morning and say, you know, kids are okay are off to daycare or you know, here's a funny picture. And you texted me one day and said you are not going to believe the amount of pee that came out of this kid. Do you remember that? Like the mattress is soaked in the floor was wet. I Slade 6:35 remember one morning, getting him out of his crib, right? And the entire mattress was soaking wet. Like everything. All the blankets were wet. The pillow was where the entire mattress was. So it was I'm like it didn't make any sense to me. Stacey Simms 6:53 Right. And you know me at work. I was kind of thinking when you trade off like we did because sleep had a restaurant for many years. So I had the kids in the afternoon and in the evening when he was working. And he had the kids every morning because I used to do a morning radio show that started at 5am. And I just remember thinking, not on my shift like you gotta fix Slade 7:14 which I did right away. Of course, drying the mattress out trying to figure out what happened, but we Stacey Simms 7:19 kind of thought it was a one off. Oh, yeah. Because it didn't happen again for a while. Yeah. And then it happened to get about three weeks later. Well, Slade 7:25 we noticed I think from that point on over the next couple of weeks that he was drinking a tremendous amount of liquid for a 18 month old or 20 month old. It was you know, and he would suck down a little 10 ounce sippy cup in like, you know, 15 or 20 seconds. It was absurd. Stacey Simms 7:45 So the the mattress wedding thing was in October, I think late October or something. And then of course, there was Halloween, which I'm sure didn't do him any favors. That was the year the kids dressed up. But it was the only matching costume we ever did. Leo was Ariel and Benny was flounder. And then, at Thanksgiving, we had family photos on the Friday of Thanksgiving that year. And then we went to the lazy five ranch. And I've told this story before one of my brothers was here, right brother David was there, right? And I posted that picture recently on Facebook of David and Benny with a giant glass of orange juice. And then we went to the lazy five ranch and of course Benny couldn't he was still in diapers and he was soaked and he was just laying down and he was exhausted. He felt like garbage. And then that Monday, we went to the pediatrician that Monday right after Thanksgiving, right? And Slade 8:37 then I mean, I think they did a fasting glucose and a few other things. And they thought he had a urinary tract infection knew and I already had suspicions that it was something more like it didn't make any sense. Yeah. And then it was a few days into an antibiotic for what they thought was a urinary tract infection and there was no change. And so his outward symptoms continued to be the same right where he drank tremendous amounts of water and liquid and was always going to the bathroom. Stacey Simms 9:08 Well on that Monday when we went to the doctor his as you said his fasting glucose was normal. It was 80. And then they did a blood draw. They must have found something in his urine, right? They must have found sugar in it because I remember they did a urine test to do a urine test on a kidney. They didn't Slade 9:24 remember that we had to kind of push for them to do an A1C like they it took a week or so. Yeah, Stacey Simms 9:30 but we didn't ask for A1C We just asked for a blood test. I didn't know what we were asking for did I remember holding you had to hold him down? Yes, I did have to hold them down Leah was in the hallway Leah remembers that remember some screaming? Slade 9:40 It wasn't exactly pleasant. Stacey Simms 9:44 Yeah, and then he did that they said I had a urinary tract infection. And I remember when we treated it he seemed to feel better once a day right just from the urinary because he did have one but you know job raucous or pediatrician friend down the street said to me Why would a healthy two year old boy have a urinary You're trying to keep keep looking. So I was convinced at this point that he was he had contracted a fatal disease. I was on the internet. I was looking at all sorts of horrible things. I thought he had kidney cancer. I really did. I was so scared. And then he seemed to feel better. And then on Saturday, they called us and David was still here. And they called us on Saturday and said, like it was an emergency get to the hospital. But they wouldn't. They didn't tell me why. Well, they did tell they thought they told me why because they told me his blood sugar was like, you know, 700, or the A1C correlated to, you know, I don't know what it was. But I remember thinking, He's fine. He looks fine. He's doing okay. Why do we have to rush to the hospital? But we did. Slade 10:33 Yeah. But I remember during that week that we kind of, we were guessing that it might have been diabetes? Stacey Simms 10:42 Oh, well, yeah. Because most people and you know, the symptoms matched perfectly. But I think it was the fasting glucose being kind of normal that threw me off. And I of course, went to worst case scenario, Slade 10:51 you went, you definitely went deeper. But you know, still concern. Yeah. Not knowing. And it's, it's a scary thing, when the doctor calls and says, Take your kid to the emergency room. And you go while he's walking around playing with some toys, he's just fine. So and then, of course, it's just a, it's a crash course. Right? You get admitted in two days later, you're out and you have diabetes and have to live with it the rest of your lives. Stacey Simms 11:19 Oh, you know, one thing I forgot is, when we took him to the pediatrician that first time on the Monday after Thanksgiving, when I called, we knew just enough to say he's got the symptoms of type one. We knew that much that the pain and the drinking, because of all the stuff I'd done with JDRF already and in Charlotte, and my pediatrician, Dr. Scott said, I've never seen it in anybody younger than two. Right, bring him in, and we'll rule it out. And thankfully, you know, they took us seriously because I've heard some nightmare stories of people that don't. But what's funny is, here we are 10 years later, almost every time I go to that pediatrician, and it's one of these big practices with like eight doctors, they all look at Benny's chart and we go in, they say, oh, like he was the youngest one we saw at that time, you know, and now of course, there's lots of kids that are diagnosed younger, unfortunately. But for that practice, it was it was unusual. It's pretty unique. Slade 12:07 Yeah, I just I just distinctly remember that we had to push a little bit. Yeah. To get them to think in that direction. Stacey Simms 12:15 Oh, when he walked in with AD, yeah, they tried to figure out something else. So Slade 12:19 I mean, I think all that really says is, doesn't matter what the age or what you're thinking, you have to be your own advocate, you know, in some way, shape or form, if you're not your voice, then there's an opportunity to miss something. Right? Not get a good look at it. So I think that I think that not going down the you know, the rabbit hole right? To something considerably more catastrophic. And trying to rule that stuff out. You have to, you have to ask and you have to instruct and you have to, you know, your medical team, you have to be part of the conversation, right? You can't just tell me what to do. Stacey Simms 13:04 But it's hard to in some ways, because you don't know what you don't know. But you're I agree with you. You have to we've learned this for many years. Now. You got to push you got to be your own advocate, you got to ask questions. But, you know, if I didn't know, peeing and drinking was a sign of type one, I don't think I would have known what to ask the doctor. Right. But Slade 13:19 I also think that that I don't think doctors are offended by that. I think that that helps them do what they're trained to do is help. Help people get better. And if you're not engaged in the conversation, it's a one way street. Yeah. It Stacey Simms 13:32 would help. Alright, so we're in the hospital now. And I remember he had those things. What are those things called all over you with a stick you the sticky things I had like an Slade 13:41 EKG monitor, right, and he kept pulling Stacey Simms 13:43 them off? Slade 13:44 Yeah, that couldn't have felt good. Stacey Simms 13:48 That was like when we first started using the Hulk analogy, because he was like the baby Hulk pulling everything off. Slade 13:54 Well, it's interesting, and he doesn't have any idea what's going on. Stacey Simms 13:57 But that night, we took turns, you know, you went home. I stayed. And they pretty much didn't tell us until the middle of the night that he had type one. They kind of I think everybody thought we knew. And finally I asked if they had a diagnosis. And they said, Yeah, he's got they would like yeah, he's got type 1 diabetes. I mean, they were nasty about it. But I think everybody thought someone else had told us along the way. Slade 14:19 We didn't see Dr. Werner alto second day or the next day. Yes. We Stacey Simms 14:23 went in on Saturday morning or Saturday, mid morning. We saw nurses and hospitalists there was that one horrible woman. She came in and she smelled. She didn't say anything to us, like not Hello, how are you? I'm so and so she came right in and smelled him. And now I know it was for fruity breath. Right? So when she came in, she smelled him. And you know, I am of course very calm. I said, What are you doing to my son? Who were you? She kind of explained but she kind of left us like you're not coming back and just I don't know what I said. I'm sure it was very nice. But yeah, that night we met the hospitalist. And that was when that was when he said to me, who stays home with Benny, not our endocrinologist, but but just a hospitalist, a doctor who sees people in hospital. And I was already panicking because I had my dream job. And I had health insurance. You had a restaurant you owned a restaurant is that like you can untangle from that pretty easily? You know, I'm closing the doors. When Slade 15:21 we tried to untangle from it, it took a long time. Stacey Simms 15:25 And I was terrified because it couldn't really quit. I wanted to quit my job. But I had to health insurance and I really didn't want to quit my job either. So we said who stays home with Benny? I said, nobody really nasty. And then I burst into tears. And you weren't there. And Vinnie, do not remember you were not there. He was another night. And then then he put his kidneys awake. He's 23 months old. He puts his arm around me. He says it's okay, Mommy. I was like, Dude, you better get your stuff together to myself. You bet this is your 10 year old is comforting you this is not how it's supposed to work. And that was a big turning point for me. And like the guy was great. He said, I'm sorry. He said, What I should have said is what's your situation? He's like, I'm just trying to help you acclimate? And he told us even go back to daycare. And he you know, nobody said no to us. They'll try to help us figure out how to make it work. But that moment was a big turning point for me. Slade 16:14 I don't think I had any big turning points. I mean, the only thing that I realized was, you know, when we finally did come home, and you know, I went grocery shopping. Stacey Simms 16:26 Oh my god, wait. So hold on. Let's get there. So we met Dr. V. The next morning on a Sunday. And he came in and I remember him coming in and saying hi to us and being great. But getting right on the floor with Benny. Yeah, Slade 16:39 and what I remember. And and you have a better memory than I do. But what I remember is him saying listen, based on where we are today with treating this. There isn't any reason he shouldn't have the exact same life he would have without diabetes that he has with diabetes. I mean, that was that was that just set the tone? Right? Stacey Simms 17:00 Yeah, it really did. And I remember, thank you. I will anyway, I remember, like my first questions to him, because what do you know about diabetes? Right? You know, type two, I remember thinking and asking him like, do I have to cut his toenails differently? Like? He was like, Oh, I could see, right? Yeah, take a deep breath. And like, this lady is gonna be fun. But he got right on the floor and met Benny and I don't think he had kids at that point. He did not. Yeah. And he was terrific. But I interviewed him. I said to him, you know, I'm glad to meet you. But you know, I don't know anything about endocrinology, or endocrinologist, or endocrinologist in this town. Right? Of course, I want to make sure that my child has the best. So I asked him a million questions. And he was great. He was really great. Yeah, Slade 17:49 I just think he set the tone that said, hey, what you're going to deal with is lifelong. And then that's the way it is. But it's not life threatening. Yeah. Doesn't have to be life threatening, right? Stacey Simms 18:03 He didn't he didn't come in and tell us a cure is around the corner. He talked a little bit about the artificial pancreas. I remember because I asked him about technology. He he did say that they were one of the first practices in the country that routinely gave pumps to toddlers, because this was 2006. So that wasn't happening all over the place that he thought that Benny we know down the road, we would talk about that. But he was not overly he didn't promise anything. Slade 18:30 No, actually he did. He promised us Benny would have a normal life if he took care of himself. Right? Well, that's true. It didn't make that that's Stacey Simms 18:36 true. And that was very reassuring. And he has been consistent in these 10 years. He said, The three things that he says at almost every appointment, I'm pretty sure he told us then, which was he wants to make sure that he can live a long, healthy life he's supposed to, that he has, he feels good, and can enjoy life right now. And that we find a way to make diabetes fit into what he wants to do, and not the other way around. And we've been able to do that pretty much. It's not you know, when people say, Oh, diabetes can't stop you. I mean, some of that I, you know, I shake my head a little bit or I raise an eyebrow because, you know, obviously diabetes definitely can slow you down. And there are days when it can stop you. That's okay. I mean, you know, when you break your leg, it's gonna stop you. You know, I you know, it's I know, it's a mindset more than a truism. But, you know, I think we've had a pretty realistic look at it. Yeah, I Slade 19:27 think you as you go through, particularly growing up, and there's, you know, there's minefields everywhere, right? It's just one more minefield, right? I mean, it's something else, you have to navigate it and it gets added into your routine added into the way that you think. And it's, yeah, it's a it's a burden because it's different than what a lot of your peers have to deal with. Is it a burden in it in that it can be a roadblock to accomplishing something you want to accomplish? like you and I think that way, I don't think that's true. Stacey Simms 20:02 We try not do not it's not a not a dead end road, you can make it that way. Well, it can be a roadblock that you can overcome, right. But it shouldn't stop you in your tracks. Slade 20:11 You can do a lot of what was me? Well, yeah, well, that's different, right? You can do a lot of what was me, but there isn't. There's a, there's a roadmap to accomplishing what you want to accomplish with diabetes. All Stacey Simms 20:24 right. Speaking of routine, let's talk about that grocery store. Slade 20:28 That was hysterical. So, you know, of course, you know, when you talk about diabetes, you talk about carbs, right. And as you load your body up with carbohydrates, you need insulin, Stacey Simms 20:38 oh, and I should add, we were put on a carb counting regime or a carb counting routine. Immediately. We didn't do any eat to the insulin, it was all give them as many shots as you want, right? And count carbs and dose him that way. Right. I mean, obviously, at first, we tried not to give him a lot of injections. But we were some people go on different routines at first, right? We weren't, we were all carb counting from the beginning, Slade 21:00 right? But it's really all about, you know, the basics of understanding how to take care of yourself is you have to know what you ingest, right? You have to know what you eat. And you can give yourself insulin to help your body, right, continue to move forward and act the way it should act right by adding an insulin. So we're like, you know, maybe we should really go low carb or no carb. So I went to the grocery store, I think I spent two and a Stacey Simms 21:30 half hours. That's what I was gonna say. It was definitely two hours. And Slade 21:34 I it's I think I know the label of every item in the grocery. But I just went and bought everything that was low carb when he came home and put it in the cupboards and put in the refrigerator and he loved some of the food and fed it to him for a few days and then realized we were feeding him fat. Yeah, Stacey Simms 21:50 we did two weeks almost of Atkins, basically. And I lost about six pounds. It was, I'm sure that had nothing to do with being crazy. But yeah, I mean, we went from eating, moderate. Everything in moderation and pretty healthy. I mean, our kids were five and not an almost two. It's not like they were drinking soda and McDonald's all the time. But we were eating things like oatmeal for breakfast and pancakes and stuff. And we went to eating sausage. And I don't it was ridiculous. Like everything Slade 22:19 was a lot of me. Yeah, it was a lot of meat and a lot of cheese. And we realized is we're just gonna, we're just eating fat, and we're gonna kill him. So after a couple of weeks, I actually threw a bunch of that stuff out. But Stacey Simms 22:29 the turning point for me or the final straw was when you were like, how about pork rinds? That's a good snack. He's doing we're Jewish. I mean, we don't keep kosher, but I don't remember. I was like, that's, I know, many people enjoy pork rinds. I'm not. I don't, I bet he would love them. Now. You can find some things, I mean, olives, beef jerky, Slade 22:56 just remember kind of throwing it out and go, that's it, we're just going to, I'm going to feed him the way we would normally feed him. And, and we will treat him medically the way that we are given the tools to do it. And that's what we're gonna do. Stacey Simms 23:08 And we also counted every carb tried to do it exactly. I think it's I think the whole thing, we figured it out two hours of routine to our day, because we had a yellow legal pad, right, we wrote everything down. We've got all the food, the dosage, the routine, but we were counting carbs, and ketchup, and green peas. And I mean everything because that's what we were told to do. Right. And I remember going for a follow up, when you go for free first followed two months later, one month later, and there was a mom and dad was like, really? This is excellent. But you do not need to do with the two cards that are in the ketchup. Well, Slade 23:40 I still think actually, that's kind of important, because you need to understand that it's out there. You need, I mean, their cards, you're ingesting Stacey Simms 23:47 what we need, and we needed to do it then to learn. Yeah. Slade 23:49 And that's what happens is you learn you know, kind of what carbs are, where they are, where they're hidden, how your body reacts to them, particularly how Benny's body reacts to them. And then it's really kind of an art at that point, right? It's not really a science. I mean, there's all kinds of ratios and logarithms and all that stuff. But it really comes down to everyone's body is a little different. And it's it's much more like juggling right than it is like anything else. Stacey Simms 24:27 I'm gonna pause my talk with Slade here and bring in our daughter Leah. She's three years older than Benny four years ahead in school because of where their birthdays fall. And about 40 years older in maturity right now, you know, it's okay to say that I was so happy she agreed to talk to me about this. And this might be the best discussion we've had about her brother and diabetes. I will say I remember a few things a little differently. But this is her story. Alright, so let's start at the very beginning. I when I talked to dad, we talked about when Benny was first day He noticed and one of the things that I brought up was when we had to take the first blood draw. You were outside of the doctor's office. Do you remember that? No, Lea 25:08 I remember the electrodes, but and him always pulling them off. But I don't remember the blood draw. We Stacey Simms 25:13 because you went to the pediatricians office with us. And he was screaming his head off, and you were in the hallway. Because you were just you just turned 508. Lea 25:21 I think I do. Remember I was playing with my LeapFrog. And I was sitting in the hallway. And I was like, I would hear screaming, but I'd be like, Oh, it's whatever. It's fine. I'm gonna play my game. Stacey Simms 25:33 And then we went when Benny was in the hospital. You remember the electrodes and Uncle David was with that Lea 25:38 was funny. I mean, because I didn't understand what was going on. So it was funny, because he had electrodes all over him. And he would just like, pull them off. So they couldn't do anything. And I mean, he was crying and like, you were very frustrated. And I'm just laughing because I had no idea what was going on. Stacey Simms 25:52 And then the next day, we actually went ice skating. It was our community ice skating thing with when we were making the temple. It was like our first time though, into the ice skating rink. Lea 26:01 Did the rabbi go, Stacey Simms 26:03 I don't think they had the rabbi yet. It was just us. And you were very little. Okay, so you remember, okay, so what do you do you remember, like, what kind of things you remember from when you were little. Lea 26:14 I remember very general stuff. I don't really remember like specific instances. Like when he was first diagnosed, I didn't think anything was wrong. But apparently he was like, drinking too much and peeing too much. And I was just like, Yeah, whatever. Because I was not the biggest fan of my little brother. And I remember, as he got older, and I think it was more, I was less of like a small child and more of like, preteen, I was very upset because he'd always get so much attention, which now it's like, you get it, because it's an awful horrible thing and all blah, he needs all this stuff. But as as a small child, it was like, pay attention to me, Mother, I exist to you have a second child who was actually your first child. But you know, it was cool. I was an only child for four years, which was a wonderful thing. Stacey Simms 27:03 It was like, almost three years. Before, it was three Lea 27:07 years. Like for almost four. Stacey Simms 27:10 It was almost three, it was three U turn three, November, whatever. And then he was boring. Okay, very similar. But I remember a lot of when you were very little as you were a big helper. Like when he was first born, you would help me with the help with the baby, you would help with diapers, you would read to him every night, you know, to get sick of him all that stuff. And the same thing with diabetes. You wanted to learn how to do everything. You guys would give shots to the stuffed animals. Lea 27:35 Oh, yeah. The Little Bear and there were like little patches on it. Yeah. That's Rufus the bear with diabetes. Oh, that's fun. Stacey Simms 27:44 That's nice. And right. So you would do that. But you were very helpful to me in the backseat of the car. Because when you have a kid in a baby seat, basically, right, he was in front facing. I don't remember what the requirements were now. But like, you'd have the three point harness the five point harness those kinds of chairs. And so you were next to him? And if he was low, you you actually checked him once or twice for me when you were like five or six years old. You did? And then yes, and then you but not often, but you were very responsible. And you were like I'll do and usually I would pull over if I needed to like if dad wasn't mad. That's I mean, it wasn't making you do it. But you did it once or twice. But you were always willing and helping me the juice boxes and stuff like that. So much Lea 28:23 has changed. Stacey Simms 28:27 But then as you got older, like you said, it became more of a why? Why him? Why are you giving all the attention kind of thing? Lea 28:34 Because I never, I mean, until now I never really fully understood what, like, why he got so much of the attention. It was always just like, you spent so much time like talking to him talking about him, like calling people about it. And just you had all this you had like Lantis and Hume along, whatever all that stuff is just words that I hear around the house. But you had all of these packages shipped, like every couple of months or like, whatever you would go to these conventions and the walks and it was just like, well, let me do my walk, Dude, where's the layup walk? Stacey Simms 29:09 Do you think we should have done a better job educating you about diabetes? Because I feel like we did tell you it's Lea 29:14 not that I wasn't. It's not that I didn't really understand what it was it was just that like, I was a child. And I still am a child, but it's like, pay attention to me pay attention to me. It wasn't that I didn't know that it was some awful thing that he like needed to have all this attention because I knew that it was just like, why can't I also have attention? It wasn't like I was trying to take it away from him. It was just like me to say him. Stacey Simms 29:37 What would your advice be to parents listening to this who have a kid with type one and other kids who don't in the family? Lea 29:43 Well, you certainly don't have to. You shouldn't like take attention away from a child with diabetes just because one of your other children is feeling a little like left out but that doesn't mean that you can be you can totally ignore that child because they're still like They're your child. They're there, they need you. But it's, I think it would be better if you if someone explained to me that, like, if you'd like sat me down, and with Benny, and been like, this is what's happening, blah, blah, blah. This is why we give them so much attention. It's not that we don't love you. And just something like that. And sure, I probably still want to complain, but whatever. Like, it's fine. Stacey Simms 30:23 So like, the little things that we tried to do, like weekends away, or just you and me stuff like that, like spending, Lea 30:29 spending a weekend with my dad or with my mom, like, that's great. Because it's, it shows like, sure you spend basically every second of every day worrying about this other kid. But you still have time for me, which is pretty awesome. Stacey Simms 30:43 So tell me about camp a little bit, because this is something that you and Benny share that you do not really share with me and your dad. You I don't know if you remember, but used to come home from camp. This is the regular summer camp slip away for about a month. And tell Benny, it's gonna be so great. You're gonna love it, you know, can't wait. So you would go and I would always think there's no way. There's no way and you were ready to go when you were eight. And when he was eight, I was not ready for him to go. But we sent him anyway. What? Do you remember why you want them to go? Did you just think he would have fun? Lea 31:14 Well, I mean, when he first went, what unit like, well, how old was I? When he first went? Stacey Simms 31:21 Well, he was bony one. So you would have been three years older than that. I don't know how we can never keep track of those things. Well, he Lea 31:26 was like eight when he when he was eight. So I would have been like 11. Yeah. So at 11 It was still very much like it will because because of the fact that he's had diabetes, and we've known for so long. It's just kind of part of our lives. And I don't think of it as like this huge deal. Like it's just something that he just has to deal with him. It's like whatever, because he's a normal kid. It's not like, it's not like some other things that people can get where like you see, like, what you see the symptoms or you see, like the damage that it does, it's just sort of something that you have to deal with. And it's just like, whatever. So, I mean, it never even occurred to me that like he wouldn't go to a sleepaway camp, because that was just like, oh, yeah, it's like, Andy has diabetes. It's like, he's got brown eyes. He's got diabetes, like whatever. So, I mean, it was it was just, like, such a fun place to like to go and to get away. And it was, like, you get to do so much there that you don't really get to do at home. And it was never, it was never about him. Like, oh my gosh, he's my brother. I love him so much. I want to come to camp. It was like, I want you to experience this wonderful place. But it was it was never, it was never about the diabetes. It was just about him wanting to like go, Stacey Simms 32:37 I don't think he ever would have gone if you hadn't been so excited about it. Because that was part of the reason I wanted him to go because you liked it so much. That was wonderful. Yeah, he's really has a good time there. I mean, I'm so glad you had such a great experience to Lea 32:50 take my place. Okay, Stacey Simms 32:52 okay. All right. So that was great. I can't Unknown Speaker 32:55 go anymore. Yeah, Stacey Simms 32:56 you're too old for camp. Now. That stinks. No, Lea 32:59 but I can go back this summer if I wanted to. Next summer next summer. Yeah, but I don't think I would I might be counselor, be counseling Stacey Simms 33:06 keep your brother in line on the different side of the camp. Okay. Has since since Benny was diagnosed, I know you've met other kids with type one. But you don't come to conferences much. So it's not like this is a hey, it's a type one atmosphere, you know, other than the walks and things? Do you feel that? First of all, have you ever talked with someone and I haven't really been asked this question. But like, do you feel like knowing about Benny's diabetes has maybe helped you get to know other kids with type one better? Lea 33:38 Not really, I mean, most of the people that I talk to, like kids my age, or adults or kids Benny's age, it's always, like, that's just sort of a thing that we both know about them that they have diabetes. And it's we don't, I mean, the most that we would ever talk about is like if they were low, or if like they had to bolus for something, and it would never be like a big deal. And most of the time, we would just talk about like, other things, just because, I mean, for me, I'm just so used to my brother having it. And for them, they have it, so they just kind of have to be used to it. So neither was ever make a big deal out of it. And it's just kind of like whatever, Stacey Simms 34:11 it would be kind of weird. For teenagers, you'd be like, so tell me about your type 1 diabetes. Lea 34:18 You wouldn't. I mean, you can certainly have a conversation with somebody else about it if you don't have it yourself. But I mean, unless you're like you're very new to what diabetes is. It's generally not a big deal. Like if you're talking to somebody who has diabetes, you generally know they have diabetes, and that's why you're talking to each other. So it's never really like a major point of discussion. If that makes any sense. Got it. Did Stacey Simms 34:47 you ever have a moment where you were scared with Benny? Lea 34:51 There was I was like, it was like five minutes where you first showed me an epi pen like in case he got like really low. Oh, the glucagon, glucagon. It's an epi pen. Stacey Simms 35:05 But it's okay. But it looks like the same thing. Lea 35:07 It does the same thing. And I remember like you came up and you showed me and it was like, this big red needle or whatever. I'd never seen anything like it. And you're and you explain the whole thing to me. Like if Benny gets really low, or this happens, or if he passes out, you have to stab him in the thigh with this giant needle. Like, if nobody else was around, you have to do it, or he's gonna die. How old was like nine, five? Stacey Simms 35:30 No, I don't think I'm kidding. I don't remember how Lea 35:35 it was before I turned 10. I remember this. And I was just like, What on earth is this? You want me to stab my brother? If he's like lying on the ground? But and you're like, keeping it in the cabinet downstairs? And it's like, what is this? But I mean, other than that, it's pretty much been totally normal. And Stacey Simms 35:52 it's funny because some of our babysitter's we found because of diabetes, and you've learned to be really good friends with them, which is pretty cool as you've gotten older. Yeah. But Lea 36:01 it was never because of their diabetes. It was just like, oh, you know how to take care of yourself. You can take care of our child. Well, it Stacey Simms 36:07 was for us it was for you had nothing to do with it. What do you care if they had diabetes, it was just one of those things that we felt, we just fell into these great, we found great people. And, you know, like our neighbor, Christina, who was diagnosed as a young adult, and now she's family friends, which is really nice. She's pretty awesome. She is pretty. So family is pretty awesome. Do you worry about Ben growing up with diabetes or being an adult with diabetes? Now? Have you ever even thought about it? Um, Lea 36:29 I'm not worried for him. Not, not with him being able to take care of himself because he's totally capable. I'm just worried about like, what other people might say about it. Because when, because, people when you hear diabetes, you think of like, generally what people think of diabetes I think of as normally type two, which you can get, which is like, generally related to like obesity, or just being overweight and not healthy. But he has type one, which is totally different. And I just, I don't know, kids are mean. I mean, really, kids are kids are mean. And I don't know, I'm not worried about him. I'm worried about everybody else. Stacey Simms 37:06 In what they're gonna say that you'll beat them up if they're meeting of course. Alright, let me just make sure before we start, people had questions. I think they were mostly for Benny, but somebody did so offended. Will do me a question. It gets all the attention. I Lea 37:21 know. Isn't it? Great? Let's see if all this it's okay to complain about your sibling getting all the attention. I think that's a great point. Stacey Simms 37:30 Definitely. It's okay to complain better than season. Lea 37:34 See thing. Don't hate your parents. They're just trying to keep your other sibling alive. Oh, Stacey Simms 37:40 this was an asked these questions. I would love your daughter's perspective. Did it cause her to be jealous? attention seeking, seeking? And how does it feel to have to worry about him? Or do you worry about him? Well, Lea 37:52 I'm gonna go with the second part of this because I feel like I've already addressed like the first part of this question, but I don't really worry about him. Like at all. It's always I know, you and dad worry about him all the time. Because it's like, what if he's not bolusing? What if he's really high? Like what's going on? But I'm just like, whatever, you can take care of himself. You won't let him die. It's okay. There's a hospital down the road, he'll be fine. I mean, I probably should worry just a little bit more than I do. But it's just, it's part of my life. It's part of his life. It's just, it's something we have to do. Well, I Stacey Simms 38:23 think what we tried to do was to make you aware, but not to make it your responsibility. I just never felt like it was your responsibility as a kid, everybody. And if you remember when he got on the bus, he was in kindergarten. So you were in fourth grade. And people a lot of people said to me, Oh, well, it's what a relief that he's on the bus because even though you can't be with him, Leah's there and she can take care of. And I never felt what I told you at the time was, you don't have to worry about his diabetes, just take care of him as a sister and brothers should take care of each other. We told him that to like, if somebody's picking on you, he needs to stand up for you. And vice versa. If you get sick, he needs to holler for help. You know, it's just that kind of stuff. It was never diabetes specific. And I know you guys looked out for each other all the time, or didn't you sit next to each other all through elementary school? Lea 39:08 No, for one grade, Stacey Simms 39:09 I think Did you really say that? I was kidding. No, Lea 39:11 I think it was no, I remember because I was in like fourth grade. So I was I was like, slowly like into like the cool part and like the back of the bus. And I was really excited about it. Because like me and all my friends. We sent like the ferry back and it was like, Oh my gosh, we're so cool. We sent back the bus. But the bus driver, it was Ben he was in like second grade or like, I Stacey Simms 39:30 don't know, I remember this. This was in kindergarten. We foster going to school to major sit together. Lea 39:34 He sat in the very front row, right? They were terrified right behind the bus driver because they were like, what if he like passes out? What if he goes totally insane where he doesn't have any food. And so they made me sit with him? Because I was at SR and like, I knew that they were olders I knew it was going on and I could like call like my mom because I knew your phone number. And I was very I was very upset. But you did Stacey Simms 39:56 that for like a week or yeah, I've been told Does Yeah, there was no, yeah. And then you were like, Mom, we need to address Lea 40:04 this. We have an issue. That's Stacey Simms 40:06 great. I forgot all about that. And he was happy to see you go to Yeah, we Lea 40:10 were both like, Go away. Get away from because my brother like he couldn't talk to females on the bus because they're like, why is your sister with you are like really awkward because like, he was like in kindergarten and I was like a cool fourth grader, not really. And so, and I was just upset because I was like, I want to go sit with my friends. Now. I don't want to do my little brother like ill. Stacey Simms 40:30 And on that note, thank you so much, sweetie. This was great. No problem. You're listening to Diabetes Connections with Stacey Simms. I am so proud of her. Even though I was biting my tongue a bit. I mean, we explained diabetes a lot with her. I am sure you know that, you know. And yes, she knows an epi pen and glucagon are not the same thing. But wow. That was that was nice for me. That was really great to talk to Leah. All right, let's go back to me and Slade. And when we left off, we were started to talk about how we try to make diabetes fit into our life, rather than making life revolve around diabetes. Before before we left the hospital, though. We had a long planned event with our congregation. That that year that summer, we had also decided to help start our temple, right. That was that summer and then this this winter, this happened. But we had a an ice skating. I had planned an ice skating event in downtown Charlotte for the Sunday the day after Benny was diagnosed. So we were still in the hospital. And we talked about it and you said you should go right. And I didn't take Leah. And so you went to the hospital that day, we traded off. And I took Leah to the ice skating rink and I was really nervous. And I was really kind of upset about leaving him in the hospital. I'm so glad I did that. I'm so glad I did that. Because it showed her that life goes on. It kind of convinced me that life goes on. It was a great fun event. And our friends and our community were amazing. They were just amazing. It was so supportive of me. And they made sure we had fun. It was great. I'm so glad we did that. That was cool. Slade 42:17 Yeah, I think that kind of sets or maybe not on purpose, but kind of set the tone for how are you we're trying to normalize we we work really hard and normalizing our lives. In fact, we live our lives first and treat diabetes second, almost, right, because it's just part of what you have to do. It's kind of like you have to put your shoes on if you're gonna go outside, right. So you have to treat your diabetes when whenever you're out and about so. But I think that kind of set the tone for it, right? I mean, because you can you can get into a dark place if you don't. Stacey Simms 42:50 Well, and Dr. Dr. V. also told us probably that day, or the next day, don't buy him a pony for checking his blood sugar. Right. Don't reward him unduly because this is not going away. Yeah, it's not like, you know, oh, boy, I Slade 43:04 think you started looking at ponies Stacey Simms 43:06 I would have looked at I was looking at Porsches looking at everything. It's really funny. You know, it's it's interesting to when you talk about life goes on. I think we put him back in daycare, right? Three days later? Slade 43:19 Well, we're very fortunate. Was it three days high? It Stacey Simms 43:22 was very soon, probably within a week. And we were lucky. Slade 43:25 But we were very fortunate in that the people who are the managers at the daycare center, had had some experience, and then took it upon themselves to go and get more training. Yeah, it was crazy. So we were really fortunate, but that that wasn't common than it was only 10 years ago isn't common, but it's very common now. So I think the challenges that people have about daycare are they're much easier barriers now than when, even just 10 years ago. Stacey Simms 43:56 I would say that there are more resources to help. But I think that daycare is a huge challenge for a lot of people. I don't know how lucky we were. Slade 44:06 Well, no, I don't disagree that it's a huge challenge. But it's there are more and more kids that are diagnosed that come through the doors at daycare centers, and they are their experience level is much higher than it was 10 years. Stacey Simms 44:19 Well, what happened with us was there was a family right before us with a little girl and the mom was a teacher and a nurse. It was crazy. So she had made a whole guide book for them and came in and trained a few people. And so when we brought Benny they knew more than we did I wanted him to sleep there. I kind of did no no. And and Rebecca who was the manager who really just became part of the family for a while. And one or two of the teachers, as you said they did more training. I sent them to one of the JDRF training days and they learned along with us they were absolutely amazing. Then that little girl moved just like three days after we came back from the hospital so they weren't even there. And then the other thing I remember, I should probably stay chronological but I'll skip ahead We had a planned trip with my friends, my college roommate with Beth and Dave, to Las Vegas in. Slade 45:06 But you know, back to the daycare thing, I think the key, the key to that is, and it's kind of the way we've always dealt with it is, our objective is when we put our son in the care of somebody else, particularly early on, our objective was to make them feel as comfortable and as confident as possible, that they that they could take care of them there or, you know, we didn't put pressure on them to say, you know, you were worried you're not going to be able to, or we were scared parents, we let them know that, you know, it's if you have to dial 911, you dial 911, it's okay, you do the best that you can with the tools that we're giving you and the tools that you have. And I think that that's, that's a hard hurdle for people to get over. But I think if you get over that, you get a lot more help. Right, and you get a lot more people who, when they're when your child is in their care that they feel confident, we all know that feeling confident, no matter what you're doing, helps you perform better. So we really worked hard at trying to instill confidence in the people that were at times across the years taking care of our son. Stacey Simms 46:16 I think we were also the beneficiaries in a weird way of less or no social media. You're not on Facebook a ton, and you're not in all these diabetes groups. But I think if if I had been when Benny was diagnosed, my outlook might be different. Because some of them have 1000s and 1000s of people in them and everybody's experience is different. And you know, it is on Facebook, you only see the best and the worst. And people post a lot of nightmare stories that other people assume are the norm, and they're not. And I think I would have been more frightened, I would have loved the support. I mean, we had nobody up here for the first couple years. We didn't know anybody. But I think that that that has added to I don't want to do a whole thing on social media here. But I think that has added to some of the fear was, Slade 47:01 I think that and because social media wasn't as prevalent as it isn't, it's the same thing, right? You believe half of what you hear and less than what you read, right? I mean, it's you have to make decisions based on your own experiences. And it's okay to view other experiences and see how they might, might influence what you're doing. But you can't, you can't say it happened to that person. So it's going to happen to me. Exactly. Stacey Simms 47:26 And I will say he was great. I mean, he had highs, he had lows, he was always safe and happy, which as you know, if you listen, that's my goal is not perfect, but safe and happy. And the one time he went to the hospital was Was he he just got his thumb caught in the door. You remember he did Slade 47:41 the same thing that other people do at daycare, they get hurt falling down, you know, somebody threw a block at his head, right? I mean, that's the same kind of stuff. And you Stacey Simms 47:51 needed stitches. That was the one thing. And I was so nervous, because that wasn't too long after diagnosis, maybe a couple months, and I'm still nervous, because my oh my gosh, how are we gonna manage diabetes? Fine. It Slade 48:01 was fine. It was easy. Stacey Simms 48:02 It was easy. So the next big thing that happened in terms of life goes on was we went to Las Vegas with my college roommate. And I called my mom because she was going to come watch the kids and my parents lived in Florida. And I said, you know, I don't know if we should do this, you know, should we stay? And life goes on. You have to go you have to go. She said, You know, this is not you know, I'll do it. I'll do it. So as we started talking about she said, but I can't give them a shot. I got it. And you know what? I think she would have if she had to she would have right? Yeah. But we were very fortunate one of the girls from daycare, who was as she was trained to be a nurse, right? She was nursing student, Kristen. She was so she came over. I met her she stayed here. But she came over and did all the insulin at the weekend. And you know and mom called us a ton we were in was the Aladdin was it? It was it was the end of the Aladdin right? Because they Slade 48:59 Yeah, it wasn't. Oh, yeah, it was yeah, they return it they were tearing Stacey Simms 49:03 down around us. And so I remember distinctly like taking a call from her getting in the elevator on the Aladdin and losing the call. And then she called me back. So when we when we mean it, but we had a great time. Slade 49:15 Was that before the show we went to what show the show when Dave Stacey Simms 49:19 No, that was that was months after the show was the following weekend. It's what you tell us. Okay, so when you tell I'll tell the story. So one week after diagnosis. We're so fortunate. My brother in law David Slate's brother says four older brothers. And David is closest in age to him. So David was staying us for like a month after Thanksgiving. It was great. He was in between jobs. And he's just so close to my kids. It was wonderful. Unfortunately for him, he was here for diagnosis. So we had tickets to spam a lot. Me and you that following weekend. So again, David's like go go I've got it. I mean, David knew just as much as we did at that point. Yeah. So we get three numbers into spam a lot. I mean to know if it was that lady of the Like, I don't know where that is, or maybe I made it up. And, you know, in the phone rings, so you go out to take the call and like 15 minutes later yeah, it wasn't because I saw three numbers I think you saw like, and I went out to see what was going on. And he thought, you know, when you think about how you dose a little kid, he was 27 pounds. He was 23 months old, and he got like little puffs of insulin. But we were using syringes, right? So he would get like a quarter of a unit or you tried to estimate a half a unit and I think he was supposed to get a half a unit and David gave him six units or something like that. Or two, you couldn't have taken two units. I mean, he had this tiny little dose and David thought he gave him four times as much right? So we couldn't figure it out. So we just said forget it. We went home. As I remember Slade 50:43 on our way home. We were driving home and he had it under we never stopped him. Did we? Yes, of course. We Stacey Simms 50:49 came home. Okay, we we didn't come home. I thought we went right to the NATs house. Okay, so he's but But what happened? Is we checked or he checked. Isn't that funny? I can't remember either. We're getting old honey. So he checked or we checked and his blood sugar never felt right. He was perfectly fine. He was like, I'll make it up. He was like 150 all night. I mean, never fell. So he couldn't have possibly either do injection? Or he never miscalculated, right? Or, or Benny snuck a pizza in the middle of the night that we didn't know about. And so we were on our way home, right. And a friend of ours had had a holiday party going on that night. We're like, I will just go there Slade 51:22 just fine. So the we left the show early, right. I mean, we're 20 minutes into the show. We laughed. We're driving home talking back and forth with David and realized he was fine. So we kept going went by the house and went to a friend's holiday party. Stacey Simms 51:35 We're terrible parents. No, we're not. I don't think we're gonna terrible parents either. That's really funny. Yeah, and that we never saw spam a lot. No, I still haven't seen it. Slade 51:48 I mean, I want to I don't know if I could bring Benny Stacey Simms 51:55 All right, um, I promise we won't go year by year, day by day through the 10 years. But just a couple of quick things about the Look at me. Like, are you sure? Slade 52:06 I don't have a good enough memory to do that, please. Stacey Simms 52:10 Benny, God has insulin pump. We talked about that with Dr. V. Right from the beginning. And he got his pump. We went to our educator to Lynette Right. And, and we said, I remember saying give me the one that's easiest for me to use, and will be the best for him. Because I was really scared of how complicated it was gonna be. And we wound up with the atom is 2020, which is what they had back then. And I showed it to Benny, and he threw it across the room. Got Slade 52:40 your hand and chucked it. Stacey Simms 52:44 Maybe this won't work out so well. But he was two and a half. You know, we kind of explained to him what the deal was. And you know, this will be a big shot every three days. But not all the shots in between that by this point. He didn't care. You could give him a shot. Slade 52:55 He would just stick his arm up like shot, he raised his arm you give me I put his arm down. He Stacey Simms 52:59 didn't care at all. At that point. He was so so good. And so used to it. But that night when he had the pump, because we had the sailing trial for a couple of days, he said, I said do you want it? I didn't know he was gonna sleep in. So I kind of said, Do you want me to take it off? And he said no mine. And that was it. He loved it. He's just he wouldn't give it up after that. So that was really good. And we had a little trouble with the very first inset we ever did. We had a capillary, there's a lot of blood member and then we weren't sure it was going to work. And we like geniuses, we decided we were going to go away to start the pump. So we went to my parents house where this was in the summer. So you I went to my parents house for a week, because when you start an insulin pump, and they probably still do this now you have to check every three hours around the clock for the first couple days to get the level, you know, close to right. I'll go with, I'll stay with my mom. My parents spent the summers in New York at that point. I'll spend the summers spend the week in New York. And then my mom can spot me with the kids. It'll be great. I'll sleep when I sleep. And you had a golf tournament with Bill in Vermont, in Vermont. And I said, Oh go I can do this. Go ahead. And you know, I'm fine. I'll be with my parents. So I remember thinking when we first had that bad inset, this isn't I'm never gonna get on a plane. This is not working. And I remember we changed it and he was, you know, we've checked in right before we got in the car to go to the airport. And luckily it was fine. So I was much calmer. We were crazy to do this Slade 54:20 as well. And I remember I was in Vermont and I don't know if I think I was supposed to pack up the diabetes supplies. Stacey Simms 54:29 I don't know. That guy was yes, you packed all the diabetes supplies and I for the record. Slade is fastidious, he is an excellent Packer. Usually what happens is I put out clothing and then you pack it. Yeah, I mean, he's really, I would trust him more than myself in terms of remembering things. So I'll give you that much credit. Yeah, well, you blew this one. Oh, I forgot to add Slade 54:51 the cartridges that you refill and then put back in the pump. And I'm in Vermont and you we're scrambling, we're on the phone, you're scrambling trying to figure out what to do. And Bill had a good friend whose son had type one. And he was on a pump. We had no idea if it was the same. But like, he calls them at like eight o'clock at night, we go to his house, he gives us a couple of cartridges. I mean, it was really, and we were ready to drive back to Manhattan, right? Or back to New York, to bring it to you. And you guys had figured out another way to Yeah, Stacey Simms 55:27 but it was really funny. Because again, before Facebook, yeah, I probably could have put out a message and said, Does anybody have this within 30 miles and somebody would have helped me out. So what happened was, we went to change the cartridge, and I'm all proud of myself, because I've got it all laid out, and I'm calm. And so we had a good start to the pump. We really, we didn't need a lot of adjusting for whatever reason the dosing worked out pretty easily pretty quickly. So when I went to change the cartridge, I was feeling maybe overconfident. So I had everything else spread out everything right. And I realized where the cartridges were the cartridges. So I called our endocrinology office, and I called our educator and the endocrinologist called back first and said, You need a luer lock needle, and what the heck and you can't get it at a pharmacy. So my dad is gone. I'm going to the hospital. And he goes to get the luer lock needle so he can say you can screw it on to the cartridge and I had insulin I had an insulin vial. So then Lynette our educator calls me back, she says, We're gonna MacGyver this thing. And she teaches me over the phone, how to, you know, open up the cartridge had to make sure that you have enough space in it and and then we just injected the insulin and it was a regular needle. So she was really helpful, and she was so happy to do it. She was fantastic. I also had called the Animus, and they couldn't do anything that night. But the next morning, they came to my mom's house in rural Westchester County, which if you're not familiar with Westchester County, there's like old she is less than I said rural Westchester County it is what is it? It's not like there are farms there. I mean, they're like Ralph, Lauren owns a farm. But what I mean is they're tiny roads, they're not well marked. I can't say that. It's Slade 57:11 like any other street it has. Your house has a number in his street name, I find it to be very confused. Like it was unmarked land and her whole western neighbor fought Stacey Simms 57:20 with machetes to get to my mother's. I was impressed that they came over the next morning, and they gave me different cartridges, different sam

Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hirsch, MD, from the UW Diabetes Institute at the University of Washington. Dr. Hirsch and Davida Kruger, NP, from Henry Ford Health in Detroit co-chaired the Endocrine Society’s type 1 diabetes fellows series. That program and this podcast episode were both made possible by unrestricted, educational grants from Abbott Diabetes Care Inc., CeQur Corp., Dexcom, Insulet, JDRF, Lilly USA LLC, MannKind Corp., Novo Nordisk, Prevention Bio, Vertex, and Tandem Diabetes Care. Show notes are available at https://www.endocrine.org/podcast/enp79-type-1-diabetes-update — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hirsch, MD, from the UW Diabetes Institute at the University of Washington. Dr. Hirsch and Davida Kruger, NP, from Henry Ford Health in Detroit co-chaired the Endocrine Society’s type 1 diabetes fellows series. That program and this podcast episode were both made possible by unrestricted, educational grants from Abbott Diabetes Care Inc., CeQur Corp., Dexcom, Insulet, JDRF, Lilly USA LLC, MannKind Corp., Novo Nordisk, Prevention Bio, Vertex, and Tandem Diabetes Care. Show notes are available at https://www.endocrine.org/podcast/enp79-type-1-diabetes-update — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hirsch, MD, from the UW Diabetes Institute at the University of Washington. Dr. Hirsch and Davida Kruger, NP, from Henry Ford Health in Detroit co-chaired the Endocrine Society’s type 1 diabetes fellows series. That program and this podcast episode were both made possible by unrestricted, educational grants from Abbott Diabetes Care Inc., CeQur Corp., Dexcom, Insulet, JDRF, Lilly USA LLC, MannKind Corp., Novo Nordisk, Prevention Bio, Vertex, and Tandem Diabetes Care. For helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

On today's episode of the Entrepreneur Evolution Podcast, we are joined by Joey Havens. is currently serving HORNE as managing partner of strategic growth. He joined HORNE in 1984 and previously served as executive partner from 2012 to 2021, leading more than 1,800 team members to build the Wise Firm while passionately living out his life's calling to help others see and reach their full potential. Prior to being named executive partner in 2012, Joey served as HORNE's managing partner of health care services and the managing partner of government services, respectively.   Joey actively challenges the mainstays of business culture and strategic planning. He advocates growing leaders faster using holistic approaches and intentional sponsorship. In addition to his weekly beBetter blog, he is the author of numerous white papers and articles, including “Becoming the Firm of the Future,” published by AICPA. He has coauthored four books during his career at HORNE. Joey is an active member of CPA Practice Advisor's Top 30 Thought Leaders, where he works with other accounting professionals to help lead and shape the industry. Joey is a frequent presenter/teacher/facilitator on creating a culture of belonging, strategic planning, and leadership development and loves to teach young professionals the “ABCs to Outstanding.”   He currently serves on the board of The Mustard Seed, a Christian community for adults with developmental disabilities, and Empower Mississippi. He is a past board member of HORNE LLP, Friends of Children's Hospital, JDRF, Make-A-Wish Foundation, and AICPA Women's Initiative Executive Committee. Joey earned a bachelor of business administration from the University of Mississippi. He attends St. Francis Catholic Church with his wife, Cathy. To learn more, visit https://joeyhavens.com/ We would love to hear from you, and it would be awesome if you left us a 5-star review. Your feedback means the world to us, and we will be sure to send you a special thank you for your kind words. Don't forget to hit “subscribe” to automatically be notified when guest interviews and Express Tips drop every Tuesday and Friday. Interested in joining our monthly entrepreneur membership? Email Annette directly at yourock@ievolveconsulting.com to learn more.  Ready to invest in yourself? Book your free session with Annette HERE.  Keep evolving, entrepreneur. We are SO proud of you! --- Support this podcast: https://podcasters.spotify.com/pod/show/annette-walter/support

Wrapping up our Diabetology 2 parter encore, diabetic diabetologist and wonderful person Dr. Mike Natter, MD is back with a little introduction covering some stuff that wasn't on the radar back in 2019, like what's the deal with this Ozempic stuff you've heard about, and then Natter from the past goes on  to answer all of your questions about blood sugar, the cost of insulin, pancreas transplants, keto, glucagon, how exercise can save your life, his most meaningful interactions with patients, pudding theft, and the best place to cry at work. Also: why you should always keep frosting in your purse.This episode is swear-free and okay for all ages, and a bleeped version of Diabetology Part 1 can be found at this link.Follow Dr. Mike Natter at Instagram.com/mike.natter or at Twitter.com/mike_natterA donation went to: JDRF.org More links at alieward.com/ologies/diabetologySmologies (short, classroom-safe) episodesSponsors of OlogiesTranscripts and bleeped episodesBecome a patron of Ologies for as little as a buck a monthOlogiesMerch.com has hats, shirts, masks, totes!Follow @Ologies on Twitter and InstagramFollow @AlieWard on Twitter and InstagramEditing by Mercedes Maitland of Maitland Audio Productions and Jarrett Sleeper of MindJam Media and Mark David Christenson Transcripts by Emily White of The WordaryWebsite by Kelly R. DwyerTheme song by Nick Thorburn

Our featured interview tonight is with Rich Rosseli. Rich has been making the Smith House brand of pipes for about five years now. His path to pipe making was paved by two gifts he received. First, he received a pipe from his uncle and discovered that he loved pipe smoking. Later, his wife gave him a pipe making kit for Valentine's Day, and the rest is history. At the top of the show, Brian will go over the JDRF Fundraiser Pipes and accessories items to bid on.